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1.1 Chronic kidney disease (CKD) 
One of the key functions of the kidneys is to filter waste products that build up in the blood. 
Renal failure determines that waste products are not removed completely or sufficiently. This 
can occur quickly (acute kidney injury) often as the result of ischemia, toxins or mechanical 
trauma (1). More often, however, the development of renal failure is gradual and insidious, 
with resultant chronic kidney disease (CKD) (1). CKD is a common and serious problem that 
adversely affects human health, limits longevity, and increases costs to health-care systems 
worldwide (1). It is often many years before noticeable loss of renal function occurs. People 
with CKD have a high risk of death from stroke or heart attack (2). 
CKD is characterized by a progressive decline in the glomerular filtration rate (GFR); the 
diagnosis is made on the basis of a reduced GFR for a minimum of 3 months (3). The Kidney 
Disease Outcomes Quality Initiative of the National Kidney Foundation K/DOQI (4) has 
proposed a classification scheme for CKD that has been widely adopted (Fig. 1.1). Stage 4 
CKD denotes a severe decline in the GFR. Patients with stage 3-4 CKD are at risk for 
progression of kidney disease and development of end-stage renal disease (ESRD) (5, 6). 
Moreover, these patients appear to be at even greater risk for the development of 
cardiovascular disease and associated morbidity and mortality (2, 5, 7). Dialysis or 
transplantation is then necessary, with loss of quality of life, decreased individual life 








Figure 1.1: Classification of chronic kidney disease 
National Kidney Foundation. K/DOQI, 2002 (4). Clinical practice guidelines for chronic kidney disease: 
Evaluation, classification, and stratification.  
CKD has increasing incidence and prevalence in developed and developing nations. The 
kidneys show the greatest age-associated chronic pathology compared with brain, liver, and 
heart (8), and one in six adults over 25 years of age has some degree of CKD (9), with 
incidence increasing with age.  
The structural characteristics of CKD include increased tubular atrophy, interstitial fibrosis, 
glomerulosclerosis, renal vasculopathy, peritubular capillary rarefaction, reduced renal 
regenerative capability, and inflammation (10, 11). These characteristics may be caused, at least 
inpart, by the gradual loss of renal energy through development of mitochondrial dysfunction 
and resultant increasing oxidative stress (OS) (1). OS is prevalent in CKD patients and is 
considered to be an important pathogenic mechanism (1, 12, 13). 
1.2 Oxidative stress (OS) 
Oxygen is the primary oxidant in metabolic reactions designed to obtain energy from the 
oxidation of a variety of organic molecules. OS results from the metabolic reactions that use 
oxygen, and it has been defined as a disturbance in the equilibrium status of pro-oxidant/anti-






reduced reactive oxygen forms are produced as an unavoidable by-product of mitochondrial 
respiration. Some of these forms are free radicals referred to as reactive oxygen species (ROS) 
(13). In addition, other extracellular factors such as hormones, growth factors, and 
proinflammatory cytokines also affect the production of OS (13-19). Further, systemic 
diseases such as hypertension, diabetes mellitus, and hypercholesterolemia; infection; 
antibiotics, chemotherapeutics, radiocontrast agents; and environmental toxins, occupational 
chemicals, radiation, smoking, as well as alcohol consumption also induce OS (13). 
OS has been identified and proven to be the root cause of more than 70 chronic degenerative 
diseases such as heart disease, cancer, stroke, diabetes, Alzheimer’s dementia, Parkinson’s 
disease, macular degeneration and other serious ailments, according to Dr Ray D. Strand, an 
expert in nutritional medicine (20). In the kidney, OS has been reported to play a critical role 
in the pathology of acute renal failure (21) and as a common pathway to chronic 
tubulointerstitial injury (22). The collective information on the role of oxidants that is derived 
from models of glomerular disease as well as progressive renal failure is impressive (6, 21-
25). 
    1.2.1 Reactive oxygen species (ROS) 
In physiological conditions, ROS produced in the course of normal conditions are completely 
inactivated by intact pro-oxidant/anti-oxidant processes that continuously generate and 
detoxify oxidants during normal aerobic metabolism (26-28). This means that normally there 
is a balance between pro-oxidant (or oxidant) and antioxidant defense systems. An imbalance 
between free radical-generating and radical scavenging systems in intact cells has been 
associated with the cell injury seen in numerous pathologic conditions ultimately leading to 






but three reactions are particularly relevant to cell injury: lipid peroxidation of membranes, 
oxidative modification of proteins, and oxidative damage to DNA (29). 
Exacerbated production of ROS and/or depletion of antioxidant defense system results from a 
myriad of different oxidative challenges that influence downstream cellular signaling thus 
inducing cellular damage or fibrogenic responses through stress-sensitive pathways and, in 
the kidney, promote renal cell fibrosis and senescence, decrease regenerative ability of cells, 
affect expression of inflammatory and extracellular matrix (ECM) genes and transduce cell 
migration and apoptosis. These factors have a stochastic deleterious effect on kidney function 
(30-34). 
The exact sources of ROS generated in biological systems under different disease states are 
always elusive as they are also a part of physiological processes. The principal intracellular 
sources of ROS include the mitochondrial electron transport system (cytochrome c oxidase 
enzyme), peroxisomes, 5′-lipoxygenase, and NAD(P)H oxidase enzymes (35, 36) whereas, 
commonly described exogenous factors involved in the generation of ROS are represented by 
inflammatory cytokines, chemotherapeutic drugs, and toxins (36). 
1.3 OS in promoting CKD 
OS is a constant feature and major mediator of CKD progression. Oxidants may contribute to 
progressive renal disease by virtue of their renal haemodynamic actions, by impairing 
glomerular selective properties, by inducing inordinate or aberrant growth responses, by 
inducing loss of cellular phenotype and apoptosis, and by promoting acute and chronic 
inflammatory responses and certain adhesion molecules and proinflammatory mediators (37). 
Traditional risk factors such as hypertension, diabetes, obesity, metabolic syndrome (38), as 
well as acute kidney injury (39), can damage the kidney directly or by enhancing intrarenal 






factors on the kidney (38). Metabolic factors such as elevated free fatty acids, high glucose 
levels or advanced glycoxidation end products (AGEs) induce ROS in vascular cells, leading 
to ongoing AGE formation and to gene induction of proinflammatory cytokines. Vice versa, 
numerous cytokines found elevated in obesity and diabetes may also induce OS thus a 
ʻcirculus vitiosusʼ may be initiated and accelerated (40). Because all factors involved form a 
highly interwoven network of interactions, the blockade of ROS or AGE formation at 
different sites may interrupt the vicious cycle. Reduction in renal OS by dietary or 
pharmacological approaches provides an appealing target for therapies directed towards the 
retardation of progressive renal injury. Most important to clinical practice, a number of drugs 
commonly used in the treatment of diabetes, hypertension, or cardiovascular disease, such as 
angiotensin-converting enzyme inhibitors, AT1 receptor blockers, 3-hydroxy-3-methyl-
glutaryl-CoA reductase inhibitors (statins), and thiazolidindiones have shown promising 
preventive intracellular antioxidant activity in addition to their primary pharmacological 
actions (40). 
1.4 OS triggering factors 
    1.4.1 Hydrogen peroxide (H2O2) 
 A reactive oxygen metabolite formed by the spontaneous or catalytic dismutation of 
superoxide anions (O2-), produced by the partial reduction of oxygen during aerobic 
respiration and following the exposure of cells to a variety of physical, chemical, and 
biological agents (Fig. 1.2). The ROS that are generated by mitochondrial respiration, 
including H2O2, are potent inducers of oxidative damage (1). Moreover, various stimuli 
including cytokines and growth factors generate H2O2 in target cells by stimulating the 






renal injury (29). H2O2-induced renal cell damage and tissue necrosis is associated with lipid 








Figure 1.2: Different sources of hydrogen peroxide 
Hydrogen peroxide can be produced extracellularly by the immunoglobulin G-catalyzed oxidation of water, by 
receptor/ligand interactions, and by phagocytic immune cells. Superoxide anions (O2-), which are produced by 
the partial reduction of oxygen by cytochrome c oxidase in mitochondria, by membrane associated NAD(P)H 
oxidase, or by 5′-lipoxygenasein the cytoplasm, are rapidly converted to H2O2 by the action of cytoplasmic and 
mitochondrial superoxide dismutase enzymes. Growth factors, cytokines, and integrins stimulate the activation 
of NAD(P)H oxidase and/or 5′-lipoxygenase. H2O2 can diffuse across membranes as indicated by the finer 
arrows. Adapted from reference 45. 
    1.4.2 Angiotensin II (ANG II) and platelet derived growth factor (PDGF) 
Angiotensin II is considered the major physiological active component of the renin-
angiotensin system (RAS). Originally, ANG II was identified as a vasoconstrictor and potent 
stimulus of aldosterone release from the suprarenal gland (46, 47), yet intensive research over 
the past two decades has provided convincing evidence for its active role as a true renal 
growth factor and proinflammatory cytokine, participating in various steps of the 
inflammatory response by a host of fibrotic pathways including, the upregulation of 
profibrotic cytokines, inflammation, modulation of renal cell proliferation and tubular 






progression of renal fibrosis (34,48-55). Beyond this, ANG II also incites OS in renal system, 
by direct induction of ROS generation (34, 56-61), (Fig.1.3). 
        1.4.2.1 Mechanism of action of ANG II  
All the components of RAS, including substrate angiotensinogen, enzymes involved in the 
synthesis and degradation of angiotensins, as well as receptors for angiotensins are present in 
the kidney (62). ANG II binds to two high-affinity receptors, the ANG II type-1 receptor 
(AT1R) and the ANG II type-2 receptor (AT2R). Signaling through the AT1R results in 
vasoconstriction, stimulation of growth, and activation of fibroblasts and myocytes. Signaling 
through the AT2R receptor results in vasodilatation and anti-proliferative responses (63). In 
addition, ANG II binds to its AT1R activating NAD(P)H oxidase, which in turn increases 
ROS generation in several tissues (64, 65) (Fig. 1.3). The NAD(P)H oxidase is a multi-
subunit enzyme and is one of the enzymatic sources of superoxide production (64).  
The angiotensinogen gene, which provides the precursor for ANG II production, is stimulated 
by NF-KB activation (65-67). Interestingly NF-KB is activated by ANG II in the kidney (68) 
through both AT1 and AT2 receptors (69). This provides an autocrine reinforcing loop that up-
regulates ANG II production. Further, nuclear extracts obtained from the cortex of kidneys 
with ureteral obstruction contained proteins that bind to an NF-KB-like sequence contained in 
the rat TNF-α gene promoter (69). TNF-α itself stimulates NF-KB activation (67), which again 
creates an autocrine reinforcing loop for enhanced TNF-α formation (Fig. 1.3). Because the 
NF-KB family of transcription factors have many potential combinations, it is possible that 
different NF-KB isotypes are activated by ANG II at different phases of the progression of 
renal disease. Transcription factors of the NF-KB family can influence directly or indirectly 
cellular events leading to tissue fibrosis (Fig. 1.3). ANG II stimulates NF-KB activation 






renal cells (glomerular mesangial cells and tubular epithelial cells) are also sources of TNF-α 
production in renal injury (70, 71). Two TNF-α receptors have been described: one with a 
molecular weight of 55 kD (TNFR1) and the other with a molecular weight of 75 kD 
(TNFR2) (72). Binding of TNF-α to its receptors activates a number of signal transduction 
pathways that result in the expression of a variety of transcription factors, cytokines, growth 
factors, receptors, cell adhesion molecules, mediators of inflammatory processes, acute phase 
proteins, and major histocompatibility complex proteins (72, 73) (Fig. 1.3). Moreover, 
increasing levels of ANG II may up-regulate the expression of several other proliferative 
factors including PDGF, TGFß1, VCAM-1, bFGF, and IGF. Most of these compounds have a 
major role in matrix protein overproduction thereby promoting cell growth and fibrosis (74) 
(Fig. 1.3). PDGF stimulates synthesis of fibronectin and type III collagen (75, 76). Also, 
stimulates TGFß mRNA and its protein in rat kidney fibroblasts, mouse macrophages and 










Figure 1.3: Angiotensin II: Role in renal injury 
(A): Angiotensin II binds to its receptor (AT1R) activating the cystolic subunits of NAD(P)H oxidase, which in 






cytokines, including PDGF. Most of these compounds participate in stimulating intracellular ROS formation and 
promote cell growth and fibrosis. Modified from references 62 and 64. 
1.5 Antioxidant systems 
In addition to non-enzymatic antioxidants such as vitamins C and E, carotenoids and 
flavonoids, cells contain a portfolio of antioxidant enzymes whose activities are directed at 
reducing oxidants. These enzymes can be distinguished by their catalytic mechanisms, 
cellular localization, and regulation. The major antioxidant enzymes involved in the catalytic 
breakdown of superoxide and/or peroxide anion radicals are superoxide dismutase (Cu-Zn-
SOD and Mn-SOD), catalase, glutathione peroxidase, and thioredoxin peroxidase 
(peroxiredoxins) (1, 78-81). They are highly efficient enzymes performing their catalytic 
reduction by dismutation (superoxide dismutase) or by utilizing: a heme prosthetic group 
(catalase), a cyclic oxidation/reduction of catalytic cysteine or seleno-cysteine residues 
(glutathione peroxidases), or an oxidation of catalytic cysteine residues (thioredoxin 
peroxidases). Peroxiredoxins have been subdivided into classes based on protein similarities 
and the mechanism of reduction of the oxidized protein (for a review see 82). For example, 
the typical 2-cysteine peroxiredoxins (2-Cys Prx) contain two highly conserved cysteine 
residues, which are both involved in the thioredoxin-coupled catalytic reduction of H2O2. 
The balance between pro- and antioxidant molecules determines the OS profile. A cell is able 
to overcome small perturbations and regain its original state. The formation and detoxification 
of ROS is tightly controlled by a homeostatic mechanism that entails a cellular protective 
response aiming at neutralizing the damage effect (29, 83). The previously mentioned 
antioxidant enzymes are examples of key players in that task. 
To measure the delicate balance that exists between OS and the system in place has given rise 






on biomarkers of OS, which are objectively measured and evaluated as indicators of normal 
biological processes or pathologic responses to therapeutic intervention.  
The localization and effects of OS, as well as information regarding the nature of the OS, may 
be gleaned from the analysis of discrete biomarkers of OS damage. 
 
1.6 OS biomarkers 
    1.6.1 Protein DJ-1 (PARK7) 
Protein DJ-1 is also known as the neuroprotective or Parkinson’s disease-related protein. 
Genetic mutations that eliminate the expression of the putative neuroprotective protein DJ-1 
are known to cause the familial Parkinsonʼs disease (PD) the most common 
neurodegenerative disorder (84-94). An accumulating body of evidence pinpointed the 
important role of DJ-1 in PD (84-94).The mechanisms by which loss of DJ-1 function 
promotes PD have been most associated with management of ROS and the oxidative damage 
(for review see 95-99). Recently, we highlighted in our laboratory, the powerful role of 
protein DJ-1 for renal cell resistance and survival under OS triggered by H2O2 (Chapter 2) and 
by ANG II and PDGF (Chapter 3). 
    DJ-1structure 
DJ-1 is a 20 kDa small protein with a sequence length of 189 amino acids. Ubiquitously 
expressed but found at higher levels in the testis, brain and kidney. Located predominantly in 
the cytoplasm and to a lesser extent in the nucleus and mitochondrion (89). Crystallization 
studies showed that wild type (WT) DJ-1 protein exists as dimers in solution (100) (Fig. 




















Figure 1.4: Structure of the wild type DJ-1 
(A): A ribbon representation of dimeric DJ-1 is shown with the molecular two fold axis perpendicular to the 
plane of the page, with one monomer in brown and other in green. The oxidation prone cysteine (C106) and the 
interacting glutamic acid (E18) are represented in each monomer. (B): Structure of the DJ-1 monomer consisting 
of an α/β-fold with 11 ß-strands (blue) and 8 α-helices (yellow), loops (magenta), and the different side chain 
residues (Cys106, His126, E18, and K130). C: carboxy terminus, N: amino terminus. Adapted from references 
100 and 101. 
 
    DJ-1 functions 
Elucidating the function and regulation of DJ-1 has been an active field of study for over a 
decade. Human DJ-1 has been primarily reported as an oncogene (102, 103). Later several 
diverse cellular roles have been ascribed to protein DJ-1: modulates transcription (104, 105) 
and androgen-receptor signaling (106), controls fertility (107, 108), acts as a protein 
chaperone (109, 110) and as a protease (111), required for correct mitochondrial morphology 
and function (112-114), required for autophagy of dysfunctional mitochondria (115), alters 
dopamine receptor signaling (116), suppresses apoptosis via interaction with kinases (117, 
118), upregulates glutathione synthesis or heat shock proteins (119, 120), and of prime 
interest its role as an OS sensor (121-128). The function of DJ-1 protein appears to be 






defends cells against ROS and mitochondrial damage, although the details of its biochemical 
function remain obscure. 
    DJ-1 mutations 
Numerous reports, including our own, utilizing in vitro and in vivo models in both 
mammalian and Drosophila systems support the idea that DJ-1 plays a protective role under 
pathological conditions where OS predominates (101, 121, 123, 124, 126, 128-134). With a 
shift of pI from 6.2 to 5.8 (135, 136), Mitsumoto et al., (2001) (135) have suggested that DJ-1 
may be directly oxidized by free radicals, because the pI shift after oxidation is consistent 
with formation of cysteine sulfinic acid (Cys106-SO2
-) (135). Hence, formation of Cys106-
SO2
- has been recognized as an important reversible posttranslational modification of proteins 
(101, 126, 129, 137-142). If the pI shift of DJ-1 represents a formation of cysteine sulfinic 
acid, then mutating these cysteine residues will block oxidation. Cysteine106 (Cys106) has 
been identified as the prime candidate for this modification (88, 100, 101, 107, 126, 129, 143-
148). Phylogenetic analysis has also underscored the significance of Cys106, as human DJ-1 
contains three cysteine residues (Cys46, Cys53, and Cys106) of which Cys106 is by far the 
best conserved (149, 150). Many studies have since shown that Cys106 is required for DJ-1 to 
confer cellular protection against OS (101, 126, 129, 133, 141, 148, 151-155). Moreover, 
Cys106 has a low thiol pKa value of ~5 and therefore exists almost exclusively as highly 
reactive thiolate anion at physiological pH (156). Bond length analysis using atomic 
resolution X-ray crystallography demonstrates that a neighboring protonated carboxylic acid 
sidechain residue (Glu18), also known as E18, donates a hydrogen bond to Cys106 and 
facilitates ionization of the thiol, thereby depressing its pKa value and  stabilizing the Cys106-
SO2
- (156). Replacement of Cys106 with other amino acids in DJ-1 resulted in a loss of 






146, 154, 156). Whereas modifying the environment around the sidechain of Cys106 could 
decouple the oxidation propensity and pKa of Cys106 without changing the cysteine residue 
itself. In 2009, Blackinton et al., (101) designed several Glu18 mutations (E18N, E18D, 
E18Q) that altered the oxidative propensity of Cys106 (Fig. 1.5) and characterized the effect 
of Glu18 mutations on cytoprotective activity of Cys106. Results demonstrated that the 
formation of Cys106-SO2
- is indeed critical for DJ-1 to regulate its ability to protect neuronal 
cells against OS and mitochondrial damage. In contrast, the oxidatively impaired E18D 
mutant where Cys106 was oxidized to the easily reduced sulfenic acid (Cys106-SO-) behaved 
as an inactive mutant and failed to protect cells. 
The influence of WT-DJ-1 mutation by superseding the glutamic acid E18 sidechain residue 
with an E18Q mutant possessing a glutamine sidechain or an E18D owning an aspartic acid 
substitution on the oxidative manner of DJ-1 in renal fibroblasic and epithelial cells is 
discussed in Chapter 3. 
 
















Figure 1.5: Structural effects of wild type DJ-1 designed mutations  
(A): Views of the stable Cys106 sulfinic acid oxidized form of DJ-1 (Cys106-SO2-). The region around Cys106 
from the crystal structure of Cys106-SO2- DJ-1 is superimposed over the structure of reduced Cys106-SO2- DJ-1. 
Stabilizing hydrogen bonds between the Cys106-SO2- and surrounding residues are shown in dashed lines, with 
the key interaction between E18 and Cys106-SO2- labeled. (B): A superposition of oxidized E18Q (darker 
model) and WT- DJ-1 (lighter model) shows that the key stabilizing hydrogen bond between residue E18 and 
Cys106-SO2- is lengthened in E18Q-DJ-1, weakening this interaction. In E18Q-DJ-1, Cys106 is oxidized to the 
Cys106-SO2-. (C): A superposition of residues of Cys106 in E18D-DJ-1 (darker model) and the corresponding 
region in oxidized WT-DJ-1 (lighter model). The E18D substitution results in structural perturbations at Cys106 
that stabilize the Cys106-SO- oxidation product and hinder further oxidation.Cys106 is oxidized to the easily 




OS is one of the major motifs in our substantial renal fibrosis project, where we are 
endeavoring to understand potential molecular mechanisms associated with the pathogenesis 
of renal disease. In this regard, the use of proteomic-based strategy was undertaken in the 
present study to screen out and identify novel molecular biomarkers of OS in renal cell line 
models exposed to different OS incites. A comprehensive comparison of proteome derived 
from control renal cells and H2O2 treated cells (Chapter 2), or cytokines (ANG II and PDGF) 
treated cells (Chapter 3) are represented. 
The distinctive observation for the involvement of protein DJ-1 (PARK7) in OS pathway by 
acquiring a pI shift, in addition to its high expression in cells treated with H2O2 (Chapter 2), 
prompted us to define in depth its physiological functional importance in renal cells 






i) To explore the renal cell proteome alteration that accompanied the cellular 
adaptation to OS and identify potential key proteins in renal cell resistance to OS. 
ii) To investigate and document PARK7 vital role in renal cells’ resistance and 
adaptation under conditions of OS by, utilizing small interfering RNA (siRNA) 
targeting PARK7 and examining the impact on cell response to OS by employing 
various assays. These are addressed in Chapter 2. 
iii)  To explore the role of protein DJ-1 (PARK7) in the profibrotic cytokines triggered 
renal fibrosis. Furthermore to investigate the effect of DJ-1 expression regulation 
on cell progression towards renal fibrosis. 
iv) To sought DJ-1 in renal fibrosis using fibrosis animal model. 
v) To exploit wild type DJ-1 and designed mutations to define the role of DJ-1 in 
balancing OS in renal fibrosis. 
vi) To characterize potential mechanism(s) of DJ-1 action by identifying its 










2. PROTEOMICS ANALYSIS IDENTIFIES PARK7 AS 
AN IMPORTANT PLAYER FOR RENAL CELL 




In this part of the work we performed a thorough comparison of proteome derived from 
control renal cells and H2O2 treated cells to explore the renal cell proteome alteration that 
resulted as a consequence to the cellular adaptation to OS. Potential key proteins in renal cell 
resistance to OS were identified, characterized and verified. In another set of experiments 
using DHR-123 agent, we confirmed the accumulation of ROS derivatives under OS 
conditions. We further investigated and documented PARK7 vital role in renal cells’ 
resistance and adaptation under conditions of OS by utilizing small interfering RNA (siRNA) 
targeting PARK7 and testing the impact on cell response to OS by morphological 
examinations and by employing the MTT viability assay. 
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3.  PROTEIN DJ-1 AND ITS ANTI-OXIDATIVE 
STRESS FUNCTION PLAY AN IMPORTANT 
ROLE IN RENAL CELLS MEDIATED RESPONSE 
TO PROFIBROTIC AGENTS 
 
 
In this part of the work we conducted an extensive comparison of proteome derived from 
control renal cells and cytokines (ANG II and PDGF) treated cells to explore the role of 
profibrotic cytokines on DJ-1 expression regulation on cell progression towards renal fibrosis. 
Further, we investigated DJ-1 in renal fibrosis using fibrosis animal model. In an attempt to 
destine and specify DJ-1 physiological functional importance in balancing OS in renal fibrosis 
we profited wild type DJ-1 (PARK7) and designed mutations to identify DJ-1 interacting 
partner proteins in renal cells using affinity purification and mass spectrometry thereby 
characterizing potential mechanisms of its action. 
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In the pathogenesis of renal fibrosis, oxidative stress (OS) enhances the production of reactive 
oxygen species (ROS) leading to sustained cell growth, inflammation, excessive tissue 
remodelling and accumulation, which results in the development and acceleration of renal 
damage. In our previous work (128) we established protein DJ-1 (PARK7) as an important 
ROS scavenger and key player in renal cell response to OS. In the present study we 
investigated the impact of profibrogenic agonists on DJ-1 and shed light on the role of this 
protein in renal fibrosis. 
 Treatment of renal fibroblasts and epithelial cells with the profibrogenic agonist ANG II or 
PDGF resulted in a significant up-regulation of DJ-1 expression parallel to an increase in the 
expression of fibrosis markers. Monitoring of DJ-1 expression in kidney extract and tissue 
sections from renal fibrosis mice model (Col4a3-deficient) revealed a disease grad dependent 
regulation of the protein. Overexpression of DJ-1 prompted cell resistance to OS in both 
fibroblasts and epithelial cells. Furthermore overexpression of DJ-1 mutant for glutamic acid 
18 (E18), involved in ROS scavenging, in which glutamic acid 18 (E18) is mutated to either 
aspartic acid (D) or glutamine (Q) resulted in a significant increase in cell death under OS in 
case of E18D mutation. Whereas the E18Q mutation did not impact significantly the cell 
response to OS, revealing the importance of the acidic group for protein DJ-1 as ROS 
scavenging more than the nature of amino acid itself. Affinity precipitation of interaction 
partners of DJ-1 and its mutants revealed both: a consistent proteomic cascade that has 
substantial physiological and pathological properties in collaboration with protein DJ-1 and, 
an important role of Annexin A1 and A5 in the mechanism of action of DJ-1 in anti-oxidative 
stress response. In addition, provided evidence for DJ-1 diverse functions; as an oxidative 
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sensor, a chaperone and/or its role at the transcriptional and posttranscriptional levels. 
Consequently, our results support the view that cellular adaptation to OS is accompanied by 
modulation of coordinated cellular and molecular events, suggest a direct correlation of 
fibrosis progression and expression of OS proteins, emphasize the current evidence for how 
the oxidative modification may regulate DJ-1’s protective function, and implicate a multistep 
pathway for the paramount protein DJ-1. 
3.2 Introduction 
Renal fibrosis is considered the final convergent pathway for progressive kidney diseases due 
to a wide range of pathophysiologically distinct processes (157). Fibrosis progression 
involves interstitial hyper cellularity, matrix accumulation and atrophy of epithelial structures, 
resulting in loss of normal function and ultimately organ failure (158-160). Although multiple 
cell types are capable of producing extracellular matrix (ECM), there is common agreement 
that renal interstitial fibroblasts are the cell type most responsible for matrix accumulation and 
consequent structural deformation associated with fibrosis (161, 162). Tubular epithelial cells 
are also observed to have the capacity to acquire a mesenchymal cell phenotype (i.e, 
epithelial-to mesenchymal trans differentiation, EMT) in the injured kidney (163). 
The pathogenesis of renal fibrosis has been depicted as a continuum of three overlapping 
phases (164). The induction phase, where cellular stimuli trigger a pro-inflammatory response 
involving the production of a large array of profibrogenic cytokines and growth factors. A 
secondary phase manifested by the localized accumulation of cytokines promoting the 
activation and recruitment of matrix producing cells from different sources to secrete 
biological active products and increase the synthesis and expression of ECM proteins. The 
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third phase is an ongoing synthesis and accumulation of matrix despite resolution of the 
primary stimulus (164). 
Angiotensin II (ANG II), the major effector peptide of the renin-aldosterone system (RAS), is 
a prime agent that has been linked to the progression of renal disease by a host of 
mechanisms. Compelling evidence suggest that ANG II is an important mediator of OS that 
stimulates intracellular formation of ROS (22, 165). Over the last decade, many studies 
described the synergistic relationship between ROS and ANG II signaling (166-168). ROS 
induced by ANG II are chief signal intermediates in several signal transduction pathways 
involved in renal pathophysiology (22, 61, 165, 169). ROS oxidize proteins and DNA that 
promote lipid peroxidation leading to an inflammatory cascade protogonized by inflammatory 
cytokines including the platelet derived growth factor (PDGF) (170, 171). Hence, ANG II-
induced ROS are key events of the fibrogenic response through stress-sensitive pathways (22, 
33, 34, 48, 172). Exacerbated production of ROS may also directly incite damage to 
biologically important macromolecules leading to generation of surrogate markers of OS (56). 
Because of the highly reactive nature of ROS, with the potential of deleterious effects on cell 
integrity, ROS must be neutralized by protective enzymes and endogenous antioxidants (34). 
Fortunately, living organisms have developed a number of antioxidant defenses to protect 
against damage from OS. These antioxidants work together in various cell compartments 
scavenging ROS (78, 79). Hence, one scope of the current study is to use proteomic profiling 
methods in an effort to characterize in renal fibroblasts (TK-173) and epithelial cells (HK-2) 
experiencing OS insulted by ANG II or PDGF the expression profiles of the various proteins, 
thereby highlighting novel molecular mediators in renal fibrosis. 
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A recent study from our laboratory (128) demonstrated that protein DJ-1 (PARK7), by 
incorporating as an endogenous antioxidant defense protein, had an added benefit in 
ameliorating the progression of fibrosis in renal cells exposed to higher OS levels.  
DJ-1 is a conserved protein ubiquitously expressed, but found at particularly high levels in the 
testis, brain and kidney (88). It is reported to be involved in diverse cellular processes. 
Initially DJ-1 was cloned as a putative oncogene (103). Later, was found to encode the protein 
involved in male fertility (107, 108, 173), and able to work in transcriptional regulation (104, 
105, 174, 175). The responsiveness of DJ-1 to OS has provided a potential functional link to 
the pathogenesis of Parkinsonʼs disease (PD) (122, 123, 129, 176). Taira et al., 2004 (121) 
indicated that DJ-1 is an antioxidant capable of self-oxidation. In addition, DJ-1 was also 
suggested to serve as a redox sensitive molecular chaperone (109). The exact function of DJ-1 
has been as yet elusive; however, its pivotal role in OS makes it a candidate to integrate 
genetic and environmental components critical for sporadic disease (87). Yet the advantage of 
DJ-1 as a potent nutritional antioxidant protecting renal cells from apoptosis and thereby its 
implication in the pathogenesis of renal fibrosis did not receive much attention. Evidence 
supporting DJ-1ʼs beneficial role in kidney are so far not documented. The present study was 
designed to determine the effect of profibrotic cytokines (ANG II and PDGF) on DJ-1 
expression. Moreover, using collagen (Col4a3) knockout mice as a fibrosis animal model, we 
attempted to investigate DJ-1 in renal fibrosis. To further define the role of DJ-1 expression in 
balancing OS in renal fibrosis, we sought to identify DJ-1 interaction partners in wild-type 
(WT) and mutant DJ-1 and characterize the mechanism of its action. 
3.3 Material and Methods 
    3.3.1 Cell line and culture procedure 
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Human renal fibroblast cell line (TK-173) used in these experiments was derived from a 
normal human kidney. The cells were immortalized by transfection with the plasmid pSV3gpt 
from SV40 and have typical morphological and biochemical properties of renal interstitial 
fibroblasts (177). The TK-173 cell line was routinely maintained as a monolayer culture in 75 
cm2 tissue culture flasks (Falcon) in Dulbecco’s modified Eagle’s medium (DMEM, Gibco), 
supplemented with 10% fetal calf serum (FCS, Gibco), 1% L-glutamine (Sigma) and 1% 
penicillin/streptomycin (Gibco). The second cell line culture consisted of renal epithelial cells 
designated human kidney-2 (HK-2). HK-2 was derived from a normal adult human renal 
cortex (178). Cultured cells were exposed to a recombinant retrovirus containing the HPV 16 
E6/E7 genes. The HK-2 cell line was maintained as a monolayer culture in Quantum 286 
medium for epithelial cells (PAA) with 1% penicillin/streptomycin. Cells were passaged at 
85-90% confluency. Before the start of each experiment, normal growing cells were harvested 
with trypsin (Sigma), and cultured in 7 ml medium at a density of 5x104 cells per flask and 
allowed to attach and grow overnight at 37ºC in a humidified atmosphere with 5% CO2. 
    3.3.2 FCS-free cell culture and cytokine treatment experiments 
TK-173 or HK-2 cells were grown to sub-confluency (~70% confluency) in 75 cm2 culture 
flasks. Medium was removed, and after washing in phosphate buffered saline (PBS, Gibco) 
the cells were incubated for a further 24 h in 10 ml serum free DMEM with regular change of 
medium every 2 h. Purified human ANG II (0.5 µM) (Sigma) or, PDGF (10 nM) (R&D 
Systems), were added to the medium, and the cells were incubated for additional 72 h with the 
two cytokines separately in separate experiments. The medium with the cytokine was changed 
every 24 h to avoid any impact of dead cells on cell proteome. A group with no additives was 
run in parallel serving as the control. Cell extracts were collected, and the proteins were 
processed as described below for further analyses. 
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    3.3.3 Protein extraction and precipitation 
The protein extraction was performed as described previously (179). Briefly, the cultured 
cells were harvested and washed 3 times with PBS. Subsequently the cells were centrifuged at 
200xg for 10 min, and the pellet was treated with 0.05-0.1 ml lysis buffer containing 9.5 M 
urea, 2% (w/v) CHAPS [(3-Cholamidopropyl)dimethylammonio]-1-propanesulfonate] 
(Sigma), 2% (w/v) ampholytes (MERCK), 1% (w/v) DTT (Sigma). After adding the lysis 
buffer, the samples were incubated for 30 min at 4ºC. For removing the cell debris, sample 
centrifugation was carried out at 13,000xg and 4ºC for 45 min. Supernatant was recentrifuged 
at 13,000xg and 4ºC for an additional 45 min to get maximal purity. The resulting samples 
were used immediately or stored at -80ºC until use. To reduce the salt contamination and to 
enrich the proteins, chloroform-methanol precipitation was performed according to Wessel 
and Fluegge (180). For the Western blot analysis of ECM proteins, the reducing agent (DTT) 
was avoided in lysis buffer to keep disulfide bridges intact. Total protein concentration was 
estimated using the Bio-Rad protein assay (Bio-Rad, Hercules, CA, USA) according to 
Bradford (181). BSA (Roche) was used as a standard. 
    3.3.4 MTT cell viability assay 
For the cell viability assay the cell proliferation Kit I (MTT) from Roche was used according 
to the manufacturer’s instructions. To investigate the effect of H2O2 (MERCK) and cytokines 
(ANG II and PDGF) on cell viability and proliferation, 5000-6000 cells were grown in a 96 
well tissue culture plate (Falcon) in control medium (for H2O2) or in FCS-free medium (for 
cytokines). After 24 h the attached cells were treated with H2O2 (200 µM), ANG II (0.5 µM) 
or PDGF (10 nM). MTT test was performed 72 h after incubation according to the 
manufacturer recommendation. For transfection experiments, cells were first transfected with 
the corresponding plasmid, the transfection success was confirmed (see Plasmids and cellular 
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transfection) then moved into the 96 well tissue culture plates for MTT analyses. All 
experiments were performed in triplicate and during each experiment 6 replicate per case 
were carried out. 
    3.3.5 Two-dimensional gel electrophoresis (2-DE)  
2-DE analysis was performed according to Dihazi et al., 2011 (179). Briefly, cell extracts 
from ANG II, PDGF treated cells or control cells were prepared as described above. A total of 
150 μg protein from each experiment was diluted in rehydration buffer [8 M urea, 1% (w/v) 
CHAPS, 0.2% ampholytes  pH 5-8 for 11-cm IPG strips, 15 mM DTT, and a trace of 
bromophenol blue]. The sample was used for the rehydration of the immobilized pH gradient 
(IPG) strips (Bio-Rad). The strips were allowed to rehydrate for 1 h before adding mineral oil 
(Bio-Rad). The passive rehydration was carried out overnight for at least 12 h at room 
temperature in a focusing chamber. Isoelectric focusing with a Protean IEF (Bio-Rad) was 
performed at 20ºC using the following multistep protocol: 500 V for 1 h, 1000 V for 1 h, and 
8000 V for 6 h.  After the first dimension, the individual strips were equilibrated in 6 M urea, 
30% (w/v) glycerol, 2% (w/v) SDS, 0.05 M Tris-HCl pH 8.8, and 15 mM DTT for 20 min. 
An additional incubation in the same buffer, supplemented with iodoacetamide (40 mg/ml), 
was carried out for another 20 min. After equilibration, the IPG strips were loaded on 12% 
SDS-PAGE, and run at 200 V for second dimension separation of proteins.  
    3.3.6 Gel staining  
For image analysis, 2-D gels were fixed in a solution containing 50% methanol and 12% 
acetic acid overnight and fluorescently stained with Flamingo fluorescent gel stain (Bio-Rad) 
for a minimum of 5 h. After staining, gels were scanned at 50 μm resolution on a Fuji 
FLA5100 scanner (Fuji Photo, Kanagawa, Japan). The digitalized images were analyzed; spot 
matching across gels and normalization were performed using Delta2D 3.4 (Decodon, 
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Germany). Delta2D computes a ‘spot quality’ value for every detected spot. This value shows 
how closely a spot represents the ‘ideal’ 3D Gaussian bell shape. Based on the average spot 
volume ratio, spots whose relative expression is changed at least 2-fold between the compared 
samples were considered to be significant. 2-D gels were post-stained with colloidal 
Coomassie blue (Roti-Blue, Carl-Roth, Germany) overnight, and differentially regulated 
proteins were excised and processed for identification.  
    3.3.7 In-gel digestion and mass spectrometry analysis of protein spots 
In-gel digestion and peptide extraction were carried out as described previously (179). 
Coomassie brilliant blue-stained spots were manually excised from the gels and washed with 
distilled water for 15 min. The destaining procedure was carried out by washing the spots 
alternately with 50% acetonitrile (ACN) and 100 mM ammonium bicarbonate 3 times for 5 
min. After dehydrating the spots with ACN for 15 min, they were dried in a vacuum 
centrifuge for approximately 15 min. Thereafter, the gel spots were rehydrated for digestion 
with 40 μl trypsin (10 ng/μl in 100 mM ammonium bicarbonate) and incubated at 37ºC 
overnight. The peptide samples were extracted with different concentrations of ACN and 
trifluoroacetic acid (TFA). Subsequently, the extracted peptides were cocrystallized with the 
matrix (25 diaminobenzoic acid) on a stainless steel target using 1 μl matrix and 5 μl sample. 
An Applied Biosystems Voyager-DE STR time-of-flight (TOF) mass spectrometer, operating 
in delayed reflector mode with an accelerated voltage of 20 kV, was used to generate peptide 
mass fingerprint (PMF) maps. Mass spectra were obtained by averaging 50 individual laser 
shots. All samples were externally calibrated with a peptide mix of des-Arg1-bradykinin 
([M+H]+904.46), angiotensin I ([M+H]+1296.68), Glu1-fibrinopeptide B ([M+H]+1570.67), 
ACTH (1-17) ([M+H]+2093.08), and ACTH (18-39) ([M+H]+2465.19), and the resulting 
mass spectra were internally calibrated with trypsin autolysis products (m/z 842.50 and m/z 
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2211.10). Monoisotopic peptide masses were assigned, and database searches in the Swiss-
Prot primary sequence database, restricted to the taxonomy Homo sapiens, were performed 
using MASCOT Software 2.2 (Matrix Science). Carboxamidomethylation of Cys and 
oxidation of Met were specified as variable modifications. One missed trypsin cleavage was 
allowed. Mass tolerance was set to 50 ppm for PMF searches. The minimal requirement for 
accepting a protein as identified was at least 30% sequence coverage in the PMF. 
Alternatively, tryptic peptides were subjected to mass spectrometric sequencing using a Q-
TOF Ultima Global mass spectrometer (Micromass, Manchester, UK), equipped with a 
nanoflow ESI Z-spray. For that purpose, gel plugs were excised from 2-D gels and digested as 
described previously. After digestion, the supernatant was removed and saved, and the 
additional peptides were extracted with increasing acetonitrile/trifluoroacetic acid solutions 
under sonication. All supernatants were pooled together, dried in a vacuum centrifuge, and re-
dissolved in 0.1% formic acid for injection in the Q-TOF. The mass spectrometric sequencing 
was performed as described previously. Processed data were searched against the MSDB and 
Swissprot databases through the Mascot search engine using a peptide mass tolerance and 
fragment tolerance of 0.5 Da. Protein identifications with at least two peptides sequenced 
were considered significant. 
    3.3.8 Western blot analysis 
Western blot (WB) analysis was performed according to Towbin and colleagues (182, 183). 
The cell extracts (40 µg per lane) were separated on a 12% SDS-gel. Blotting was performed 
on nitrocellulose membranes (Amersham Pharmacia Biotech, Buckinghamshire, UK) at 40 V 
for 24 h in transfer buffer (25 mM Tris-HCl pH 8.4, 192 mM glycine, 0.5% SDS, 20% 
methanol). The membranes were blocked in 5% non-fat dry milk in PBS buffer containing 
0.1% Tween-20 for 2 h at 37ºC. The incubation with the primary antibodies was carried out 
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overnight at 4ºC. Mouse anti-DJ-1 (Sigma), rabbit anti-PRDX6 (Abcam), rabbit anti-SOD1 
(Abnova), rabbit anti-PRDX1 (Abcam) and mouse anti-ACTB (Sigma), were used as primary 
antibodies. Alexa Fluor 647 goat anti-rabbit IgG antibody, or Alexa Fluor 647 goat anti-
mouse IgG antibody were used as secondary antibodies (Molecular Probes). Before imaging, 
the blots were dried in the dark. The blot membranes were scanned at a resolution of 50 μm 
on a Fuji FLA5100 scanner with single laser-emitting excitation light at 635 nm and 670 nm, 
respectively.  
In case of Col4a3 knockout mice, three animals per group were sacrificed at weeks 4.5, 6.5, 
7.5, and 9.5, and as control three WT animals were used. The kidneys from all animals were 
harvested. Aliquots of tissue extracts from three kidneys of different animals (40 μg protein) 
were dissolved in SDS-sample buffer, separated by electrophoresis in an SDS-polyacrylamide 
gel (12%) under reducing conditions, transferred to a nitrocellulose membrane, and blocked 
for 60 min at room temperature with 5% milk-powder in a 0.2 mol/L Tris-HCl buffer, pH 7.6, 
containing 0.1% Tween 20 solution (TBST buffer). Antibodies against mouse DJ-1, rabbit 
PRDX6, rabbit SOD1, rabbit PRDX1, rabbit FN1 (Sigma), mouse VCL (Sigma), and rabbit 
GRP78 (Sigma) as the primary antibodies were diluted in blocking buffer, then added to the 
membrane and allowed to incubate for 60 min. The addition of secondary antibodies, 
membrane scanning, and analysis were performed as described above. 
    3.3.9 Immunohistochemical and immunofluorescence analyses of kidney 
……….. sections 
Immunostaining of deparaffinized and rehydrated sections was performed to monitor the 
expression of DJ-1 and PRDX6 proteins. Following antigen retrieval pretreatment in 0.01 M 
citric acid using a standard steamer for 25 min, endogenous peroxidase was inactivated with 
3% H2O2 in PBS for 10 min at room temperature in the dark. Sections were blocked with 10% 
goat serum in PBS for 1 h and incubated with either anti-DJ-1 or anti-PRDX6 primary 
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antibody overnight at 4ºC. Primary antibodies were detected with HRP labeled secondary 
antibody for 1 h at room temperature (GE Healthcare). For negative controls tissue sections 
were incubated only with the secondary antibody. The detection reaction was developed with 
3,3-diaminobenzidine (Sigma) for 10 min at room temperature in the dark. Nuclei were 
counterstained with hematoxylin before examination. All tissue sections were dehydrated in 
graded alcohols and xylene and embedded in mounting solution Entellan (Merck). 
Similar primary antibodies were also detected with fluorescence Alexa 555-conjugated goat 
anti-rabbit or Alexa 488-conjugated goat anti-mouse secondary antibody (Invitrogen) as 
recommended. Slides were rinsed and mounted with Vectashield 4,6-diamidino-2-
phenylindole (DAPI) (Vector Laboratories) for visualization of nuclei. 
    3.3.10 Plasmids and cellular transfection  
Construction of DJ-1 expression vectors (wild type and mutants) has been provided by 
Addgene (https://www.addgene.org/mission/) and purchased as ready plasmids: pGW1-Myc-
DJ-1-WT (Myc tag protein), pDEST40-DJ-1-E18Q and pDEST40-DJ-1-E18D (6xHis tag 
proteins). All constructs were amplified in E-coli and verified by sequencing. The transfection 
was performed using transfection reagent Lipofectamine 2000TM (Invitrogen) according to 
manufacturersʼ standard protocol. In brief, 2 µg of plasmids and 8 µl of Lipofectamine 
2000TM were added to 100 µl OptiMEM (Gibco). The mixture was gently mixed, incubated at 
room temperature for 20 min, and then added drop-wise to cells (TK-173 or HK-2) cultured to 
approximately 70% confluence. After 24 h, transfection media were changed with normal 
culture media supplemented with 0.5 mg/ml G-418 (Invitrogen) as a selection factor for stable 
transfection. Cells were maintained in the selection medium for 14 days to achieve stable 
transfection and assessed for protein expression by WB. 
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    3.3.11 Protein immunoprecipitation 
         3.3.11.1 For WT-DJ-1 (Myc tag protein) 
To identify the potential interaction partners of DJ-1 WT, immunoprecipitation using anti-DJ-
1 coupled to G-protein agarose matrix was performed. The cell lysates were harvested from 
transfected and control cells as described above. To remove potential backgrounds, the 
protein samples were adjusted to 1 ml with PBS buffer and 50 µl G-agarose matrix (Roche) 
were added to each sample. The mixture was incubated for 3 h at room temperature under 
agitation then centrifuged at 12,000xg for 30 sec. The supernatants were removed to new 
tubes and 5 µl anti-DJ-1 antibody were added to each sample. The immunoreaction was 
carried out overnight at 4ºC under agitation. 50 µl protein G-agarose matrix were added to 
each sample. The mixture was incubated at 4ºC under rotary agitation for 4 h. The samples 
were centrifuged and the supernatant removed. The G-agarose matrix was washed three times 
with PBS buffer. The protein elution was performed by incubating the samples in 30 µl of 
2xloading buffer at 95ºC for 5 min. Subsequently the samples were centrifuged to remove the 
G-protein agarose, and the supernatant was used to run SDS-PAGE and identify the binding 
proteins. 
         3.3.11.2 For E18Q-DJ-1 and E18D-DJ-1 (6xHis tag proteins) 
For the identification of the potential interaction partners of DJ-1 mutants E18Q and E18D, 
His-tag affinity purification was carried-out. The QIA express Ni-NTA Fast Start Kit 
(Qiagen) was used and the protein purification was performed according to the provider 
protocols. Briefly, cells were harvested from transfected and control cells as previously 
described. Each cell pellet was re-suspended in one ml of the prepared native lysis buffer 
(Supplied native lysis buffer was supplemented with lysozyme and benzonase nuclease by 
dissolving the contents of the lysozyme vial in 600 µl of native lysis buffer. For use, 100 µl of 
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the lysozyme solution were added to a 10 ml aliquot of native buffer). The suspensions were 
incubated for 30 min on ice with 2-3 gentle swirling then centrifuged at 14,000xg for 30 min 
at 4ºC. Each sample was allowed to flow in a Fast Start column then washed 2 times each 
with 500 µl native wash buffer. Bound 6xHis-tagged proteins and their potential interaction 
partners were then eluted twice using 100 µl native elution buffer for each elution. 5 µl 
4xSDS-PAGE sample buffer were added to 20 µl of the last elution sample fraction. SDS-
PAGE protein separation and in-gel digestion mass spectrometric analysis of the samples 
were carried out as described above.   
    3.3.12 Bioinformatics  
The classification of the identified proteins according to their main known/postulated 
functions was carried out using DAVID bioinformatics (http://david.abcc.ncifcrf.gov/).This 
classification together with the official gene symbol was used to investigate and categorize the 
gene ontology (GO)-annotations (subcellular location and molecular function). 
    3.3.13 STRING analysis 
The types of evidence for the association of the immunoprecipitated proteins suggesting their 
different functional links were quantitatively integrated using STRING 9.05 database 
(functional protein-protein interaction networks) (http://string-db.org). 
    3.3.14 Statistical analysis 
All blots were quantified using the ImageJ software. For comparison between two measures 
(in the same group) the paired t-test was used. The unpaired t-test (for comparing two groups) 
or one-way ANOVA (comparing three or more groups) were used. Graphpad prism software 
package was used for graphical presentation. Results are expressed as the average (mean±SD) 
of three or more independent experiments. Differences were considered statistically 
significant when p<0.05. 
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    3.4.1 Profibrotic cytokines affect renal cell viability through induction of OS 
ANG II has systemic and local effects favoring cell proliferation. In addition, ANG II can 
induce the expression of different growth factors, which in turn participate in stimulating 
intracellular ROS formation and contribute to the pathogenesis of renal fibrosis. We attempted 
to investigate the response of cells stimulated with ANG II or PDGF using MTT cell viability 
assay. After several trials for different ANG II and PDGF concentrations used in literature, a 
concentration of 0.5 µM for ANG II and 10 nM for PDGF were found to impact the cell 
proliferation and induce OS without significant effect on cellular apoptosis in TK-173 and 
HK-2 cell models (Fig. 3.1A, B). For this reason, the concentrations mentioned were chosen 
for our further studies. The viability assay revealed that after 72 h incubation with ANG II or 
PDGF, both cell types showed significant increase (P<0.05) in cell growth compared to the 
control (Fig. 3.1A). When comparing both profibrogenic agonists, treatment with PDGF 
seems to accelerate the cell proliferation more than ANG II, which may indicate that OS 






Figure 3.1: MTT cell viability assay 
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(A): 5000 TK-173 or HK-2 cells/well were cultured in 96 well cell culture plates, incubated with H2O2, ANG II 
or PDGF stress for 72 h. For ANG II and PDGF treated cells, cells were deprived from FCS in the medium 24 h 
before treatment. The cell viability was measured and plotted in the form of bar diagrams with the cell treatment 
on x-axis and cell viability on y-axis. Results are represented as a mean of 12 readings ±SD. (B): Fluorescence 
microscopy comparing DHR-123 stained control and treated (ANG II and PDGF) TK173 and HK-2 cells. Cells 
were stained with DHR-123 for 30 min and visualized using specific filter sets for phase contrast and rhodamine. 
The obtained images were merged to observe cell morphology. Scale bar = 100 µm. The fluorescence expression 
quantification is presented as grouped bar chart under each experimental condition. Results are given as the 
means ±SD. Statistical significance was assumed for p-values <0.05: *P<0.05, **P<0.01, ***P < 0.001 with 
respect to their corresponding control.  
In confirmation to our previous study (128), the H2O2 at a concentration of 200 µM 
significantly inhibited cell viability in both treated cell groups 72 h after stimulation. The 
quantitative and statistical evaluation results are presented in Figure 3.1A comparing the 
actual response of TK-173 cells and HK-2 cells to their representative control group. H2O2 is 
an OS inducible that confers cellular OS in vivo, as we reported previously (128). 
    3.4.2 Mapping of renal cell proteome alteration upon cytokine treatment 
Although much has been learned about the molecular mechanisms underlying the pathways 
by which cytokines activate renal fibrogenesis, an integrated proteomics pattern identifying 
the altered proteins remains elusive.  
One scope of this study is to characterize key specific proteins showing alteration in their 
expression in cytokine treated cells (TK-173 and HK-2) compared to control ones. For this 
purpose, proteomic analysis was performed. 2-D protein maps from cell lysate of the different 
treated groups are presented in Figure 3.2 (A, B). All identified proteins that showed 
difference in expression under the distinct experimental conditions are numbered and 
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indicated in Figure 3.2 (A, B) and are listed in Tables 3.1 and 3.2 for TK-173 cells and Tables 















Figure 3.2B continued 
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Figure 3.2: 2-D reference maps of proteins extracted from TK-173 and HK-2 cells 
150 μg proteins were loaded on an 11-cm IPG strip with a linear pH gradient pI 5-8 for IEF; 12% SDS-
polyacrylamide gels were used for the SDS-PAGE. Proteins were stained with Flamingo fluorescent gel stain. 
Identified spots were assigned a number corresponding to that in their table. (A): For TK-173 cells and (B): For 
HK-2 cells. (a): 2-D map under ANG II treatment and (b): 2-D map under PDGF treatment. 
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    3.4.3 Ontogenic classification of the proteins involved in cell response to 
……      profibrotic cytokine treatment 
To gain more information on the biological mechanisms of the identified proteins, which are 
associated with cytokine treatment we used DAVID bioinformatics 
(http://david.abcc.ncifcrf.gov/). Each identified protein was assigned to cellular components, 
functional categories and biological process based on the Gene Ontology (GO) annotation 
system. Under all experimental conditions, the highest percentage of the identified proteins 
was found located in the intracellular part of the cell (Fig. 3.3A, B). Interestingly, GO 
assignment to molecular function illustrated that a large part of the regulated proteins were 
involved in stress response (Fig. 4A, B). Moreover the percent of stress responsive proteins in 
TK-173 cells was 35.9% for ANG II treated cells and 34.5% for PDGF treated cells. 
However, a lower percentage was obtained in HK-2 cells: 26.4% in cells exposed to ANG II 
and 26.5% in cells subjected to PDGF treatment (Fig. 4C). Our findings indicate that although 
the number of the differently regulated identified proteins was almost equal in TK-173 and 
HK-2 cell samples (Tables 3.1-3.4), the percent of stress responsive proteins was higher in the 
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Figure 3.3: Gene Ontology (GO) classification of differently regulated proteins in TK-  
…………….173 and HK-2 cell lines by DAVID bioinformatics  
The list of genes to be analysed was uploaded into Gene list Manager window and Homo sapiens was chosen as 
background. The gene list was then submitted to DAVID conversion tool. Based on the corresponding DAVID 
gene IDs and threshold adjustment (Max-Prob≤0.1 and Min Count≥2) in Chart Option section, functional 
annotations associated with each gene were displayed in a chart. GO analyses of subcellular location are 
represented as pie charts showing the different categories.Values in figures presented the ratio distribution of 
proteins found in that respective category. (A): TK-173 cells and (B): HK-2 cells.  (a): ANG II treated cells and 







Protein DJ-1 and its anti-oxidative stress function play an important role in renal cells mediated 






















Figure 3.4: GO annotations for biological processes and molecular function  
Assignment of identified proteins into groups using DAVID bioinformatics database resource. The list of genes 
to be analysed was uploaded into Gene list Manager window and Homo sapiens was chosen as background. The 
gene list was then submitted to DAVID conversion tool. Based on the corresponding DAVID gene IDs and 
threshold adjustment (Max-Prob≤0.1 and Min Count≥2) in Chart Option section, functional annotations 
associated with each gene were displayed in a chart. GO analysis of molecular function was chosen. (A): Pie 
charts of the biological processes in which the identified proteins from both treatments and in both cell types are 
involved. Most of the proteins are involved in metabolic and cellular processes. A large part of the identified 
proteins were found to be involved in immunity defense and stress response. (B): Pie charts of the classification 
Protein DJ-1 and its anti-oxidative stress function play an important role in renal cells mediated 





of the molecular function of the identified proteins. The classification revealed an activation of OS response 
pathways and alteration in the expression of proteins involved in anti-oxidative response. Moreover stress 
proteins, e.g. heat shock proteins and cytoskeletal proteins, were also regulated. (C): Percent stress responsive 
protein under each treatment is represented as a bar chart. 
Among the stress proteins which were regulated as response to ANG II or PDGF treatment in 
both cells, protein DJ-1 was significantly upregulated in both cell types and under both 
treatments.  In our former study, we established protein DJ-1 as OS responsive protein in 
renal cells (128). The present study confirmed the role of DJ-1 as a pivotal protein in the OS 
response in kidney cells. DJ-1 is a molecule that occupies an important role in cellular biology 
and is reported to be involved in diverse cellular processes. The fact that DJ-1 promotes cell 
survival by protecting neural cells (121, 129), and recently renal cells (128) from OS; and that 
knockout of the DJ-1 gene enhances cytotoxicity mediated by H2O2 (128, 184) had enthused 
our group to further explore the potential role of DJ-1 in kidney fibrosis. Interestingly, the 2-
DE experimental results clearly implicate protein DJ-1 as an OS marker protein in renal cells. 
Figure 3.2 depicts the over expression of DJ-1 in fibroblastic (Fig. 3.2A) as well as epithelial 
cells (Fig. 3.2B) agonizing OS triggered through treatment with profibrotic cytokines (ANG II 
and PDGF). However, no shift in the protein pI value that resulted in the formation of a more 
acidic isoform was observed as a result of stress induced by the profibrotic agents as we 
previously demonstrated in similar cells subjected to the OS inducer H2O2 (128) or in human 
endothelial cells exposed to paraquat (PQ2+), which generates ROS within cells (135) thereby 
suggesting different pathways for DJ-1 action in restraint to the stress stimulating agent. 
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    3.4.4 Immunoblotting validation of protein expression alteration 
To validate the data obtained from 2-DE experiments, we confirmed using WB, the 
involvement of DJ-1 in renal response to cytokine triggered OS. In addition, other first line 
defense key proteins against OS namely PRDX6, SOD1, and PRDX1 could also be 
confirmed. Overall results represented in Figure 3.5 show apparent marked increase in all OS 
marker proteins tested after 72 h of cell culture with PDGF, ANG II, or TGFß1. Statistical 
evaluation of the experimental results obtained in Figure 3.5A elucidates high significance 










Figure 3.5: Western blot analysis of expression changes of OS marker proteins under 
…………….OS induced by the different cytokines (PDGF, ANG II and TGFß1) 
The cell extracts from TK-173 and HK-2 (Control, PDGF, ANG II and TGFß1 72 h treated cells) were used. 
(A): Blots were probed with antibodies against the appropriate protein. ACTB was kept as control. (B): Bar 
charts representing the quantification of the blots. Results are given as the means ±SD from three independent 
experiments. *P<0.05, **P<0.01, ***P<0.001with respect to their corresponding control. 
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    3.4.5 Analysis of OS protein expression alteration in animal model of 
……….fibrosis: Involvement of DJ-1 in renal fibrosis 
We further attempted to investigate the role of DJ-1 in renal fibrosis. For this purpose, we 
utilized the Col4a3 knock-out mice tissue as a fibrosis animal model (www.jax.org) 
predisposed to develop CKD. The Col4a3 deficient mice have a normal phenotype until 4 
weeks of age. Abnormal renal glomerulus basement membrane morphology and irregular 
thickening and splitting of the glomerular basement membrane can be seen only by electron 
microscopy at 4 weeks of age (185). Occasionally minor glomerular lesions can be observed 
at 6 weeks of age by light microscopy. At 10 weeks of age, mice demonstrate 
glomerulosclerosis associated with inflammatory cell infiltration, interstitial fibrosis, and 
tubular atrophy (185).  
In the present work, we applied whole kidney lysate of wild type (WT) animals and that of 
different stages of Col4a3 knock-out mice for WB analysis. Figure 3.6A demonstrates blots 
reflecting and comparing the response of OS markers (DJ-1, PRDX6, SOD1, and PRDX1), 
fibrosis markers (FN1, and VCL), and the ER-stress marker protein GRP78 at the distinct 
stages. Bar diagrams representing the quantification of the blots (Fig. 3.6B) apparently 
illustrate a parallel increase in response of OS markers with the increase of the fibrotic stage. 
However, significance was only attained at the 7.5 week except for SOD1 where 6.5 week 
showed P<0.05 significance. Fibrosis marker proteins and ER-stress marker protein displayed 
no discrepancy from their corresponding control WT during the primary stages. At 7.5 week 
an abrupt raise that sustained in the 9.5 week was evinced (Fig. 3.6B). 
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Figure 3.6: Western blot analysis of OS and fibrotic markers in whole kidney lysates of   
…………… WT and different stages of Col4a3 knockout mice as a fibrosis model 
(A): Blots were probed with antibodies against the appropriate proteins. ACTB was kept as control. (B): Bar 
diagrams representing the quantification of the blot. Results are given as the means ±SD from three independent 
experiments. *P<0.05, **P<0.01, ***P<0.001 with respect to the WT. wk: week. 
    3.4.6 Immunohistochemical and immunofluorescence staining 
To further validate and characterize DJ-1 role in renal OS and subsequent fibrosis, we sought 
to determine the expression status of the protein in different parts of the Col4a3 knock-out 
mice kidneys using immunohistochemical and immunofluorescence staining. Figure 3.7 (A, 
B) shows immunohistochemical staining images of the glomerular and tubulointerstitial areas 
from WT and representative sections from each group (4.5 wk, 6.5 wk, 7.5 wk, and 9.5 wk) 
respectively stained with DJ-1 (upper panel) and PRDX6 (lower panel). PRDX6 staining was 
employed for resembling aspects to that of DJ-1. The images reveal progressive increase in 
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both DJ-1 and PRDX6 expression concomitant with the progression of renal fibrosis as 
evidenced by HE stained tissue from the same used animals (Fig. 3.7C). In parallel to 














Figure 3.7: Immunohistochemical staining of DJ-1 and PRDX6 as OS markers 
(A): Representative images of glomerular and tubulointerstitial areas from WT and different stages of Col4a3 
knockout mice kidneys stained with DJ-1 (upper panel) and PRDX6 (lower panel). Magnification (x20). The 
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immunohistochemical staining of the kidney tissue from these stages showed clear expression of DJ-1 in 
proximal tubule of the Col4A3 mice compared to WT. The DJ-1 expression became more prominent at 7.5 wk 
and 9.5 wk especially in the proximal tubule. At 9.5 wk the DJ-1 expression showed even interstitial staining 
indicating an increase in the number of interstitial fibroblasts. A similar staining behavior was observed for 
PRDX6. (B): Higher magnification of the previous images (A) showing the localization of proteins 
(Magnification x40). (C): HE staining of kidney from Col4a3 mice presenting the different stages of fibrosis. 
The tissue show a normal kidney structure without any sign of injury at the 4.5 wk of age, the tubulointerstitium 
shows intact structure with no pathological manifestation. At 7.5 wk the first signs of tubulointerstitial fibrosis 
emerged and became more prominent in tissue from animals at the 9.5 wk. 
 In concert with the immunohistochemical staining results, immunofluorescence staining of 
the analogous tissues using similar antibodies for DJ-1 and PRDX6 localization detection, 
exhibited a comparable staining pattern with strong expression of the proteins in tubular part 
especially in proximal tubule and less in the glomerulus (Fig. 3.8). A gradual rise in protein 
expression was concurrent with OS augmentation. At 9.5 wk the DJ-1 expression became 









Figure 3.8: Immunofluorescence staining of DJ-1 and PRDX6 as OS markers 
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Representative images of glomerular and tubulointerstitial areas from WT and different stages of Col4a3 
knockout mice kidneys stained with DJ-1 (upper panel) and PRDX6 (lower panel). Magnification (x20). Marked 
increase in the expression of both proteins was observed with the increase of the fibrotic stage. 
Thus, tissue staining confirmed WB results and reinforced the crucial role of DJ-1 in OS and 
its prominence as an endogenous antioxidant defense protein in the kidney. 
For figuring, strewing, and supporting purposes, other OS marker and fibrotic marker proteins 
were examined in parallel to protein DJ-1 in the various experiments. 
    3.4.7 Over expression of DJ-1 and its mutant forms and their effect on renal 
……      cell viability 
In light of the imminent importance to understand the role of DJ-1 and elucidate its high 
expression as an endogenous antioxidant defense protein in renal cells during OS; we 
transfected our experimental cell models (TK-173 and HK-2) with WT-DJ-1 and mutant 
vectors (pGW1-Myc-DJ-1-WT, pDEST40-DJ-1-E18Q, and pDEST40-DJ-1-E18D) in a series 
of separate experiments. Transfected cells were then subjected for MTT test to investigate the 
impact of transfection on cell survival under untreated and treated (H2O2, ANG II, or PDGF) 
conditions. 
DJ-1 in humans is a homodimeric protein of 189 amino acids. Crystallization structural 
analysis of the purified protein DJ-1 has led to the identification of three cysteine residues at 
amino acids numbers 46, 53, and 106 (Cys46, Cys53, and Cys106) and the first speculation 
that Cys106 is the most sensitive one to OS (148). The conserved Cys106 is both functionally 
essential and target of oxidation. Consequently, the oxidative modification of Cys106 has 
been proposed to allow DJ-1 to act as a sensor of cellular redox homeostasis and to participate 
in signaling cytoprotective pathways in the cell (126). Furthermore, atomic resolution X-ray 
crystallography and UV spectroscopy showed that C106 thiolate accepts a hydrogen bond 
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from a protonated glutamic acid sidechain (E18) that is required to maximally stabilize the 
C106 thiolate (156). Hence, we investigated the impact of E18 mutation on oxidative behavior 
of DJ-1 by utilizing DJ-1 mutants: E18Q possessing a glutamine side chain substitution and 
E18D having an aspartic acid substitution. Cells (TK-173 and HK-2) were transfected with 
plasmids expressing E18-C106 (WT), E18Q-C106 (mutant 1), and E18D-C106 (mutant 2) 
separately. Over-expression was confirmed by immunoblotting. Figure 3.9 (A) reveals the 
efficiency of the DJ-1 transfection analyzed by immunoblotting. Quantification of blots 
indicated significant increase in DJ-1 expression in all transfected cells compared to non-







Figure 3.9: Western blot analysis of DJ-1 for TK-173 and HK-2 cells before and after 
…………… transfection 
(A): Western blot analysis of TK-173 and HK-2 cell lysates before and after transfection with wild type WT-DJ-
1, and mutants E18Q-DJ-1 and E18D-DJ-1 plasmids. Over expression of DJ-1 antibody compared to control 
cells indicates successful transfection. ACTB antibody was loaded as control. (B): Bar charts representing the 
quantification of the blots. Results are given as the means ±SD from three independent experiments. *P<0.05, 
**P<0.01 with respect to their corresponding control. 
To assess whether the over expression of DJ-1 affects the cell survival under OS conditions, 
the cell viability assay was carried out with cells transfected with plasmids coding for WT and 
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mutants. The OS conditions were generated by treating the cells as described in material and 
methods section. Interestingly, over expressing the DJ-1 mutant E18D-DJ-1 markedly 
suppressed the growth in both used cell lines. The effect was more pronounced in case of the 
fibroblasts cell line TK-173 cells (Fig. 3.10A, B). Subsequent treatment with H2O2, ANG II, 
or PDGF did not add significant changes to the effect of the E18D-DJ-1 plasmid transfection. 
Significant (P<0.05) additional suppression was attained only in HK-2 cells under H2O2 
treatment (Fig. 3.10B). In contrast, the viability of the cells transfected with either WT-DJ-1 
or E18Q-DJ-1 was not significantly altered compared to the control cells in both cell lines 
(Fig. 3.10A, B) indicating that under normal cell conditions, DJ-1 augmentation is 
dispensable for cell survival. In case of ANG II and PDGF treatment the overexpression of 
WT-DJ-1 or E18Q-DJ-1 did not affect significantly the cell reaction to cytokines application 
(Fig. 3.10A, B). One explanation of this unexpected result could be that ROS in low level 
stimulated the cell proliferation but were dispensable for maintaining this impact. 
Accordingly, the scavenging effect that might had resulted from the overexpression of DJ-1 
did not affect the cells’ proliferation. The negative effect of H2O2 on cell proliferation could 
be slightly restored through overexpression of WT-DJ-1 or E18Q-DJ-1 (Fig. 3.1, Fig. 3.10 A, 
B). It seems that the overexpression level of the proteins was not sufficient enough to 
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Figure 3.10: Cell Viability test for transfected TK-173 and HK-2 cells and after 
transfrction    transfection combined with H2O2, ANG II or PDGF treatment 
Cells were transfected with the required plasmid according to manufacturer’s standard protocol then moved into 
the 96 well tissue culture plates. 5000 control (untransfected) or transfected (WT-DJ-1, E18Q-DJ-1, or E18D-
DJ-1) TK-173 or HK-2 cells/well were cultured in 96 well cell culture plates. Groups of each experimental 
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cellular status were then incubated with H2O2 (200 µM), ANG II (0.5 µM) or PDGF (10 nM) for 72 h. For ANG 
II and PDGF treated cells, cells were deprived from FCS in the medium 24 h before treatment. The cell viability 
was measured and plotted in the form of bar diagrams with the cell treatment on x-axis and cell viability on y- 
axis. (A): TK-173 cells and (B): HK-2 cells. Results are represented as a mean of 12 readings ±SD. Statistical 
analysis was performed using Graphpad Prism 4 software and the paired t-test for comparison between two 
measures in the same group and the unpaired t-test for comparing two groups. Statistical significance was 
assumed for p-values <0.05. *P<0.05, **P<0.01. Significance shown by an arrow indicates the comparison 
between the control untransfected cells (TK-173 or HK-2) and the untreated E18D-DJ-1 TK-173 or HK-2. 
Otherwise significance was calculated for each separate untreated and treated condition. 
 
    3.4.8 Immunoprecipitation and identification of the DJ-1 interaction    
………   partners 
To identify potential interaction partners of DJ-1 and to shed light on its mechanism of action 
in renal cells, immunoprecipitation and mass spectrometry analyses were combined. For this 
purpose, cell lysates from TK-173 or HK-2 cells expressing an empty vector (control), a Myc 
tag WT or a 6xHis-tagged mutant (E18Q or E18D) were used to overexpress the target forms 
of DJ-1(Figure 3.11A). The proteins and their potential interaction partners were then purified 
either with protein G agarose for the WT DJ-1 or with Ni-NTA metal-affinity 
chromatography for the His-tagged proteins following the protocol described in material and 
methods section. After repeated PBS wash and protein elution, the proteins were precipitated 
and resolved on SDS-PAGE gels. The potential interaction partners in all three cases were 




Protein DJ-1 and its anti-oxidative stress function play an important role in renal cells mediated 















 Figure 3.11: Immunoprecipitation (IP) and protein identification in transfected TK-
……………….173 and HK-2 cells 
(A): IP and protein identification in control (empty vector) and transfected TK-173 and HK-2 cells. 
Protein-protein interaction for (a): WT-DJ-1 using G-protein agarose matrix and antibody against DJ-1, (b): 
Protein-protein interaction for mutant E18Q-DJ-1, and (c): mutant E18D-DJ-1 E18D-DJ-1 (6xHis tag proteins) 
using QIA express Ni-NTA Fast Start assay. DJ-1 was immunoprecipitated with its interaction partners. The 
resulting proteins were separated using SDS-PAGE and identified using tryptic digestion and mass spectrometry. 
M= marker, 1 and 2= TK-173 cells, 3 and 4= HK-2 cells. T= transfected, C= control empty vector.  
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(B): IP and protein identification in transfected TK-173 and HK-2 cells (a): Protein-protein interaction for 
WT-DJ-1 (b): mutant E18Q-DJ-1, and (c): mutant E18D-DJ- The empmty control was skipped. Under each 
case, DJ-1 was immunoprecipitated with its interaction partners. The resulting proteins were separated using 
SDS-PAGE and identified using tryptic digestion and mass spectrometry. All identified proteins are listed in 
Tables (3.5-3.7). 
 
Protein DJ-1 and its anti-oxidative stress function play an important role in renal cells mediated 




























Protein DJ-1 and its anti-oxidative stress function play an important role in renal cells mediated 





To investigate the impact of alteration of C106 thiolate stability on interaction partners of DJ-
1, comparative analyses were performed with the immunoprecipitated proteins from the three 
cases (WT, E18Q, E18D) (Fig. 3.12). A coordinated proteomic cascade that has fundamental 
physiological and pathological properties was detected to cooperate with protein DJ-1. Six 
prime proteins, namely PRDX1, PRDX6, ANXA2, ACTB, HSPA5, and HSP90B1 were 
identified in all transfected cell groups. Peroxiredoxins (PRDX) are a ubiquitous family of 
antioxidant enzymes that are involved in redox regulation of the cell as well as in the 
protection against oxidative injury (82, 186). Regarding annexins (ANXA), several 
subfamilies have been identified based on structural and functional differences (187). ANXA2 
being a pleiotropic protein is generally implicated in diverse processes, depending on its 
cellular localization. It plays a main role in the regulation of cellular growth and signal 
transduction pathways (188). Recently, ANXA2 has been identified as novel cellular redox 
regulatory protein (189). Heat shock proteins (HSP) are a class of proteins entangled in the 
folding and unfolding of other proteins. Production of high levels of HSP is triggered by 
exposure to various kinds of environmental stress conditions (190). Their up regulation is 
described as part of the stress response. Actins (ACTB) are highly conserved proteins that are 
concerned in cell motility, structure, and integrity (191). Moreover, GAPDH, ENO1, and 
PKM2 proteins were also noticed to be shared between WT-DJ-1 and E18Q-DJ-1 transfected 
cells. It is noteworthy mentioning, that GAPDH beside its classical glycolytic function and its 
involvement in many metabolic functions, has been implicated in a diverse non-metabolic 
processes including transcription activation and initiation of apoptosis (192-194). Fukuhara et 
al., 2001 (194), stated that GAPDH acts as a reversible metabolic switch under OS. In case of 
ENO1 protein, is generally known to play a part in growth control and hypoxia tolerance 
(195). PKM2 is a glycolytic enzyme involved in a variety of pathways and protein-protein 
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interactions (196). The precipitation of more annexins namely ANXA1 and ANXA5 and the 
heat shock protein HSP90AA1 may provide an additional clue to the cellular recovery 










Figure 3.12: Comparison between immunoprecipitated proteins as potential interaction   
……………   partners of different forms of DJ-1 
Diagrammatic presentation showing the number of immunoprecipitated proteins in each experimental set and the 
proteins shared between the different sets.  
Finally, despite more OS marker proteins (PRDX2 and SOD2) were identified as interacting 
partners for E18D-DJ-1 variant (Figs. 3.11C and 3.12), yet transfecting cells with this mutant 
showed severe apoptosis (Fig. 3.10 A,B) indicating that in case of the DJ-1 the amino acid 
E18 and not its negative charge is that important for cell survival under stress conditions. 
Moreover, comparing the number of the supplemental precipitated proteins in cells 
transfected with DJ-1 mutants (Fig. 3.12) reveals that more proteins were co-precipitated with 
DJ-1 protein under E18D-DJ-1 transfection outlining the enhancement of additional cellular 
pathways in response to severe stress condition. 
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 The present data provide a framework linking DJ-1 to OS and afford insight into the 
interaction between complex mechanisms and multistep pathway by which DJ-1 exerts its 
action. In fact, functional and association networks analyses of the immunoprecipitated 
proteins using STRING: 9.05 (http://string-db.org/), revealed a strong networking of the 
identified proteins, suggesting a functional link between these proteins and their importance in 
the mechanism of action of DJ-1 (Fig. 3.13). STRING quantitatively integrates interaction 
data from four sources: Genomic context, high-throughput experiments, conserved co-








Figure 3.13: STRING 9.05: Functional protein association networks 
Database of known and predicted protein-protein interactions. The interactions include direct (physical) and 
indirect (functional) associations; they are derived from four sources: Genomic context, high-throughput 
experiments, conserved co-expression and previous knowledge. STRING quantitatively integrates interaction 
data from these sources. The evidence view for the immunoprecipitation experimental results suggesting the 
different functional links of (A): WT-DJ-1, (B): E18Q-DJ-1, and (C): E18D-DJ-1. Different line colors 
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A number of kidney diseases and their progression to end-stage renal disease are driven, in 
part, by the effects of ANG II. Increasing levels of ANG II may, in turn, up regulate the 
expression of a large number of growth factors including PDGF. Most of these compounds 
promote cell growth and fibrosis (62, 197). Well-documented growth-promoting effect of 
angiotensins in various tissues has been reported (198-203). The ANG II-stimulated blood 
vessel growth has been previously demonstrated in some experimental models (204-206). In 
addition, results of many studies have reported that peptides from the angiotensin family are 
involved in the regulation of cell growth, proliferation, migration, apoptosis, differentiation 
and inflammation (207-209) of many types of cells, including fibroblasts (210), 
cardiomyocytes (211), and renal proximal tubular cells (212). 
Similar to ANG II, PDGF isoforms were also observed to stimulate the replication and 
migration of myofibroblasts in fibrotic processes, including renal fibrosis (213), whereas 
antagonism of PDGF-D isoform prevented renal fibrosis in an experimental model of 
glomerulonephritis (214, 215), and treatment with anti PDGF-C antibody induced fibrosis in 
obstructive nephropathy (216). 
Our results are consistent with and advance the results from Piastowska-Ciesielska et al., 
2013 (217), by demonstrating that ANG II had a significant effect on viability of renal cells 
(TK-173 and HK-2) in a dose and time-dependent manner. A statistically significant 
difference between the control and treated cells with maximal survival response was achieved 
at a concentration 0.5 µM ANG II which was then chosen for further experiments. 
The prevailing interpretations existing for cell proliferation under ANG II treatment are   
either, via mitochondrial metabolic activity (217), through signaling pathways mediated by 
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the AT1 receptor (218, 218), or are often the consequence of ANG II-induced activation of 
many cytoplasmic tyrosine kinase and transactivation of membrane associated growth factor 
receptor kinases (220-222). In mammalian cells, ANG II mediates biological effects through 
binding to two classical angiotensin receptors. Interestingly, ANG II induced cell proliferation 
by activating AT1-receptors, while stimulation of the AT2-receptor inhibited cell growth in 
different cell types (223-225). The effect of ANG II on prostate cancer cells (LNCaP) 
viability was generally similar to the control (226). The lack of ANG II effect in the later 
study (226) was, in part, due to the short incubation time with ANG II (24 h) compared to 
other published studies demonstrating proliferation stimulation of the similar cell type 
cultured in presence of ANG II for 3 days (227) and for 5 days (222). 
Our proteomic analysis of renal cellsʼ response to ANG II and PDGF treatment helmed to the 
identification of a vast number of proteins, which may be directly or indirectly involved in 
cytokines regulated events. The expressions of proteins involved in the metabolic, 
cytoskeletal, inflammatory, biological, cellular homeostasis, and cell proliferation processes 
were significantly altered. Some of the proteins that were positively identified in our study 
were previously shown to be regulated directly or indirectly by growth factors. Disulfide 
isomerase and lactate dehydrogenase have been shown to be up-regulated in vascular smooth 
muscle cells (228, 229) and primary fibroblasts (230) upon exposure to PDGF. PHB, AHSA1, 
and PAK2 were also quantitatively altered in the later study (230). In respect to the abundant 
proinflammatory proteins identified in our study (heat shock proteins, annexins, tubulins, 
redoxins and collagens), previous work also reported that ANG II up-regulated the expression 
of some proinflammatory genes (connective tissue growth factor, collagen and fibronectin) 
through the activation of several intracellular signaling systems (231-233). The elucidation of 
the exact role of each specified protein is of dignified prominence and claims further 
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investigation for inspecting their relevance to renal fibrosis. However, the activation of the 
endogenous antioxidant defense mechanism that was marked by the concomitant up-
regulation of stress responsive proteins was of our central interest. 
Multiple stimuli and agonists, including ANG II and PDGF have been shown to ultimately 
induce OS (61, 234) and increase ROS production (56). ANG II-induced OS and ROS are 
pivotal in several signal transduction pathways and redox-sensitive transcriptional factors 
involved in renal pathphysiology (22,165). Schieffer et al., 2000 (235), demonstrated that 
ANG II played an important role in modulating the expression of the proinflammatory 
molecule (IL-6) through a mechanism that required the production of ROS. In year 2004 and 
later in 2006 a regulatory role of ROS in PDGF and ANG II induced signal transduction was 
further documented (236, 237). Acute ANG II infusion experiments into naïve rats in the 
presence or absence of various free radical scavengers showed that scavengers partly inhibited 
cellular damage (238, 239). ANG II-mediated ROS formation is thus substantial for renal 
growth processes that are part of an adaptive process of surviving nephrons during chronic 
renal injury (240). 
Our prior study (128) has focused on providing evidence for the critical role of protein DJ-1 
during OS acquired by H2O2 in cultured human renal fibroblasts and epithelial cells. In an 
attempt to reveal the effect of profibrotic cytokines on DJ-1 expression in the similar cell 
lines, the present survey additionally displayed that the fibrosis triggering cytokines (ANG II 
and PDGF) treatment, resulted in cellular DJ-1 up-regulation in both tested cell lines despite 
no change in the protein pI value was observed compared to the formerly detected shift under 
H2O2 treated cells, suggesting a crucial biological in vivo significance of DJ-1 as a modulator 
of OS and/or fibrosis possessing discipline functions during renal injury. Moreover, our 
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investigation of DJ-1 expression in renal tissue of mice model for renal fibrosis (Col4a3 
knock-out mice) confirmed the augmentation of the protein with the progression of fibrosis.  
It is worthwhile mentioning that the incubation of the prostatic benign cells (exhibiting low 
basal level of DJ-1 expression) with TNF-related-apoptosis-inducing-ligand/Apo-2L (TRAIL) 
had led to the enhancement of DJ-1 expression associated with the induction of apoptosis. 
While in cancer cell lines expressing relatively high DJ-1 level, rendered cells resistant to 
TRAIL with no further modulation of the polypeptide level, proposing that DJ-1 played a 
differential role between cells expressing a low but inducible level of DJ-1 and those 
expressing a high but constitutive level (241). Similarly, Zhang et al., 2008 (242), also found 
that the basal level of DJ-1 appeared to be inversely correlated with TRAIL-induced apoptosis 
in the investigated thyroid cancer lines. However, no isoelectric focusing phoresis was 
represented in both studies. In 2009, Waak and coworkers (243) demonstrated that after 
activation with the endotoxin lipopolysaccharide (LPS), DJ-1 deficient mouse astrocytes 
showed dramatic overproduction of the inflammatory mediator nitric oxide (NO), proposing 
that loss of DJ-1 may selectively derepress an LPS-activated TLR4-ASK1-p38MAPK 
pathway, leading to an overshoot of iNOS induction and consequently excessive NO 
production. This may contribute significantly to secondary neurodegeneration. Recently, it 
was also demonstrated that Toll-like receptor 4 (TLR4), the main receptor for endotoxin 
(LPS), mutant mice developed less interstititial fibrosis in comparison to WT mice and were 
protected from progressive CKD in a low-dose ANG II infusion +5/6 nephrectomy model, 
suggesting that TLR4 may play an important role in kidney scarring and fibrosis and 
contribute to CKD progression (244). Linking these observations to our cytokine (ANG II and 
PDGF) treated renal cell models and the observed protective role of DJ-1 an exact molecular 
mechanism by which DJ-1 may regulate proinflammatory signaling via TLR4 pathway in 
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renal cells remains to be rigorously proven. To present the precise impact of DJ-1 in renal 
fibrosis remains entirely ambiguous. To our knowledge, our previously published work (128) 
is the sole attempt that has been as yet executed. However, several pieces of information are 
available in literature, which provide clues to possible pathways and allow hypotheses linking 
DJ-1 to renal fibrosis thereby assisting, in collaboration to our results, to accentuate the 
multiple effects of DJ-1. 
It has been reported that DJ-1 functions in multiple pathways that promote cell survival. 
Enormous studies indicated that DJ-1 is an antioxidant that can quench ROS by self-oxidation 
(121, 129, 151). Consistent with this observation, our previous notification that gene deletion 
or down regulation of DJ-1 by small interfering RNA (siRNA) sensitize renal cells to OS 
(128), similarly neuronal cells (245), and to ER stress (245) and enhances cytotoxicity 
mediated by MPTP (184).  
DJ-1 has been modified under OS both in vitro and in vivo by oxidation of the Cys106 residue 
to form cysteine sulfinic acid (Cys106-SO2
-) (109, 126, 146, 154, 245). The formation of 
Cys106-SO2
- has been identified as a key modification required for DJ-1 to exert its protective 
function (101, 129, 133, 141, 148, 153-155, 245). Altering the oxidative propensity of Cys106 
caused the protein to lose its normal protective activity against oxidative stressors in a number 
of systems (100, 142, 246). The substitution of M261 and over-oxidation with H2O2 showed 
an increased propensity to aggregate and decreased secondary structure (142). Likewise, loss 
of protein function caused by the Parkinsonʼs-associated mutation L166P was interpreted due 
to disruption of the C-terminal region and dimerization of the protein (100, 246). Moreover, 
X-ray crystallography analysis suggested that the carboxylic acid sidechain E18 residue forms 
a hydrogen bond with Cys106-SO2
-, which is important for the stabilization of the modified 
residue (101, 126, 129, 156, 247). 
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Like WT protein (101), mutant E18Q-DJ-1 allowed Cys106 to be oxidized to Cys106-SO2
-. In 
contrast, E18D-DJ-1 mutant was oxidized to the easily reduced cysteine sulfenic acid 
(Cys106-SO-) resulting in oxidation impairment of Cys106 (101). Mitochondrial fission assay 
in the later study (101), demonstrated that E18Q could partially substitute for WT-DJ-1, while 
the oxidatively impaired E18D behaved as an inactive mutant and failed to protect cells from 
OS. Examining the role that the specific formation of Cys106-SO2
- has on cellular protective 
function of DJ-1 by mutating E18, our transfection viability assay results clearly emphasizes 
that the oxidative modification of Cys106 to Cys106-SO2
- is a critical determinant for DJ-1 to 
protect renal cells against loss of viability due to H2O2 and cytokines exposure.  
Interestingly, despite E18D was proved to have identical pKa value to E18N (126, 156), 
different oxidative and in vivo protective capabilities were later demonstrated for the two 
mutants (101), denoting that it is the oxidative propensity rather than the nucleophilicity or 
general reactivity of Cys106 that is required for DJ-1 protective activity. 
Based on the viability assay results for transfected cells presented herein and data reported by 
Blackinton et al., 2009 (101), we would suggest that E18D substitution has led to the 
tremendous disruptive effect as a result of the formation of a functionally compromised DJ-1. 
Mutation of Cys106 to alanine, serine or aspartic acid eliminated the ability of DJ-1 to protect 
against OS in several model systems including various types of cultured mammalian cells 
(101, 129, 141, 152). Similarly, L166P mutant abrogated DJ-1 function by destabilizing the 
native homodimer (88, 248, 249), and M261 mutant exhibited reduced protective activity as a 
result of decreased ability to undergo oxidation to the functionally important “2O” form (93, 
101, 110, 126, 129, 142, 250) with deleterious effects on DJ-1 function. 
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Interestingly, knockdown of DJ-1 in the corneal endothelial cells (CEC) resulted in decreased 
translocation of Nrf2 to the nucleus and significant down-regulation of Heme oxygenase 1 
(HO-1). These in vitro data corroborated findings detected in Fuchs endothelial corneal 
dystrophy (FECD) tissue samples where DJ-1 down-regulation was accompanied by 
diminished Nrf2-regulated antioxidant defense (251). Since FECD has been shown to be an 
OS disorder (252) possessing an oxidative modification at Cys106 of DJ-1 occurring during 
OS and rendering DJ-1 inactive (251), authors speculated that the oxidant-antioxidant 
imbalance seen in FECD had led to irreversible oxidative modifications of DJ-1 and its rapid 
degradation, which in turn affected the cytoplasmic stability of Nrf2 and impaired its nuclear 
translocation. DJ-1 down-regulation resulting in attenuated gene expression of Nrf2 and its 
target gene HO-1 leading to increased oxidative damage has been then repeatedly cited in 
CEC (253), in mouse kidneys and proximal tubule cells (254), and in rat heart-derived H9c2 
cells (255). Similarly Sun et al., (256) suggested that the activation of DJ-1/Nrf2 pathway was 
involved in the pathogenesis of diabetic nephropathy in rats. 
Targeting the DJ-1/Nrf2 axis may provide a potential mechanism by which DJ-1 can mediate 
the delayed protection and enhance its antioxidant defense under OS in our renal cell model. 
Given the established apparent oxidation of Cys106, can DJ-1 function be regulated in terms 
of intracellular redox state thus believed as a typical peroxiredoxin-like protein? Published 
data are conflicting. Several studies indicated that Cys106 residue of DJ-1 can undergo 
reversible oxidation in response to OS although the mechanism(s) involved in regenerating 
the non-oxidized isoforms and controlling Cys modification in DJ-1 have yet to be established 
(129, 148, 151). Others illustrated that DJ-1 is a new type of scavenger protein (101, 121). 
Wilson, 2011 (126) invoked that DJ-1 oxidized at Cys106 is not reverted to the thiol and 
accumulates as the oxidized isoforms. Turnover of the oxidized isoforms and new synthesis of 
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the reduced protein would be, therefore, required for the clearance of the oxidized DJ-1 (110). 
However, this is a convincing observation clarifying the provided evidence that DJ-1 
functions as a cytoplasmic redox-molecular chaperone of alpha-synuclein (109, 110, 119, 
257). The oxidation of Cys106 was obviously critical for the ability of DJ-1 to translocate to 
the mitochondria (129), inhibit mitochondrial fragmentation (101, 258, 259) or suppress 
alpha-synuclein fibrillation (110). Consequently, DJ-1 is not a ROS detoxifying enzyme like 
the peroxiredoxins, glutaredoxins or catalase, the true catalysts competent of multiple 
turnovers and massive ROS detoxification. Yet DJ-1 was observed to elevate glutathione 
levels (119, 257) by increasing the transcription and enzymatic activity of glutamate cysteine 
ligase, the rate limiting enzyme of glutathione synthesis (119). 
Our immunoprecipitation data provide further clues for DJ-1 suggested chaperone activity and 
its cytosolic RNA-binding activity. Under all experimental conditions, proteomic approach 
targeting DJ-1 interacting partner proteins, revealed the co-precipitation of heat shock 
proteins HSPA5 and HSP90AB1, additionally HSP90AA1 in WT and E18Q experiments, the 
premium chaperones assisting to refold misfolded proteins and suppress their aggregation in 
the presence of OS and other stress conditions. Consistent with our observation, previous 
reports manifested that OS enhanced the interaction between DJ-1 and the heat shock protein 
70 (Hsp70) (260). DJ-1 was also shown to be protective in cooperation with Hsp70 against 
alpha-synuclein toxicity in cultured human and rat cell models (120, 257), and to act in an 
Hsp70-dependent manner in cultured human dopaminergic cells (119). 
In light of the earlier report characterizing DJ-1 as a regulatory subunit of a 400 kDa RNA-
binding protein complex (173), coupled with the co-purification of glyceraldehyde 3-
phosphate dehydrogenase (GAPDH), possessing functional links to apoptosis (192-194), with 
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these complexes, together with the co-precipitation of GAPDH with DJ-1 in WT and E18Q 
but not E18D in the current work immunoprecipitation experiments, provide insight and 
distinctly expand DJ-1 function at the transcriptional level by influencing stress response gene 
expression. This observation may also explain and clarify the drastic negative effect of E18D 
substitution on cell viability. Interestingly, the yeast genes encoding DJ-1 and GAPDH 
homologs were induced during cell stress together with chaperones, antioxidants and other 
stress response proteins (261). 
An explicit role of annexins in DJ-1 multiple pathways, to our knowledge, has never as yet 
been explored. However, extracellular annexins have been linked to inflammation and 
apoptosis (262). Generally, annexins function as scaffolding proteins to anchor other proteins 
to the cell membrane (263). ANXA1 has been implicated in apoptotic mechanisms by 
promoting the removal of cells that have undergone apoptosis (188, 264). Recently, ANXA2 
has been identified as a novel cellular redox regulatory protein that played a significant role in 
cells undergoing OS induced by H2O2 via the reaction of its cysteine residue with H2O2 
resulting in the oxidation of this residue and the conversion of H2O2 to H2O (189). Over 
expression of ANXA2 as an OS sensitive protein in cells treated with H2O2 in our previous 
work (128), and in fibroblastic cells treated with OS prompting factors ANG II and PDGF in 
the present study, supports the later observation. Further, the co-expression of ANXA2 as a 
partner protein to the WT-DJ-1 and both mutants emphasizes that ANXA2 is unique among 
the annexins that possesses redox sensitive cysteine as previously stated (189). Yet the 
possible interacting mechanism with DJ-1 warrants extra investigations.  
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Referring and counseling to the functional protein association networks procured via STRING 
database, a variety of predicted protein-protein interactions through disparate enzymatic 
pathways could be speculated. 
Moreover, the remarkable and apparent precipitation of key players OS marker proteins 
(PRDX2 and SOD1) with DJ-1 in experiments for E18D mutant, clearly interprets the 
extreme stress condition challenged by cells as a result of E18D substitution. 
Our data strengthens previous determinations for DJ-1 diverse pathways and indicate that DJ-
1 is part of a concerted and complex cellular response to OS. Although much work remains to 
be done to clarify the relationship between DJ-1 and renal dysfunction, yet results reported 
here lay the ground work relevant to develop better strategies for defining the precise activity 
of DJ-1 that is responsible for cellular protection against OS in renal cells. 
Dividing the cellular response to stress inducing agents into three major steps, a protective 
response, a repair response, and a signaling and activation response, a spectacular switching 
action for the 20 kDa multifunctional protein DJ-1 according to the exact need of the cell, 





















































Oxidative stress (OS) has been implicated in human disease by a growing body of facts. The 
kidney is a highly vulnerable organ to damage caused by OS and large number of literature 
has been concerned with the link between OS and renal diseases. OS is known to desperately 
affect the survival and proliferation of renal cells through biomolecular pathways resulting in 
impairment of kidney function and final progression of renal tubulointerstitial fibrosis. Hence, 
renal fibrosis is a state of chronic deterioration of oxidative mechanism due to enhanced 
reactive oxygen species (ROS) release. Over production of ROS has been implicated as a 
driving force, which evokes a cascade of oxidative damage that can eventually result in renal 
failure. To understand the molecular basis in renal fibrosis with respect to regulation and 
expression of stress responsive proteins, we aimed to explore the effect of H2O2, and the 
profibrotic cytokines (ANG II and PDGF) as promoters of OS. In our study, human renal 
fibroblasts (TK-173) were used as they are believed to be the primary effector cells with 
respect to renal fibrogenesis process responsible for the synthesis and deposition of ECM 
components. Human renal epithelial cells (HK-2) were additionally investigated for 
comparison purposes. Our proteomic approach; 2-DE combined with mass spectrometry 
analysis has made possible the identification of OS associated proteins, among these, markers 
of the OS pathway were highly regulated in treated cells. DAVID database resource for 
assignment of the proteins according to their molecular function, showed that the percent 
stress responsive proteins was more in the fibroblastic TK-173 compared to the epithelial HK-
2 cells under treatments. The up-regulation of the over viewed proteins could be interpreted as 
one of the major cellular recovery response after oxidative damage. The information obtained, 
in the present study, has far revealed relatively comprehensive view in protein expression, 
facilitating the determination of novel OS biomarkers for early disease detection and new 






DJ-1 (PARK7) was found to acquire a pI shift in addition to its high expression under H2O2 
treatment. An important clue to a possible role in OS, as relevant from accumulating studies 
strongly suggesting the expression of PARK7 in cellular defensive response to OS and has 
been repeatedly cited to possess a pI shift in neurodegenerative diseases linked to OS. 
However, it is worthwhile mentioning that the absence of PARK7 pI shift under fibrosis 
triggering cytokines (ANG II or PDGF) treatment, surmise a crucial biological in vivo 
significance of PARK7 as a modulator of OS and/or fibrosis possessing discipline functions 
during renal injury. Knockdown of PARK7 using siRNA led to significant reduction in renal 
cell viability that was further enhanced under H2O2 treatment. MTT cell viability assay 
together with microscopic morphological investigation elucidated that suppression of 
endogenous PARK7 protein simultaneously with OS induction resulted in massive cell death 
and increase in apoptosis compared to controls. Therefore, we have put forward, for the first 
time, a specific and novel hypothesis for the vital role of PARK7 in OS resistance in renal 
cells, a protein originally discovered as an oncogene, and was later found to be responsible for 
the early onset of Parkinson’s disease. Based on this finding we sought to intensively 
investigate the expression and the role of PARK7 in balancing OS in renal fibrosis. Western 
blot (WB) analysis for lysates of H2O2 or cytokine treated cells showed the upregulation of all 
stress and fibrotic marker proteins tested including PARK7. Moreover, investigation of 
PARK7 in Col4a3 knockout mice, as a fibrosis animal model, revealed the parallel increase of 
PARK7 with the progression of fibrosis as evident by WB analysis for tissue lysate samples 
and documented by immunofluorescence and immunohistochemical staining of the tissues at 
successive stages of fibrosis. Consequently, PARK7 (DJ-1) confers protection against OS and 
enhances cell survival when challenged with OS and/or pro-apoptotic stimuli. Although the 






observation that may connect the established role for DJ-1 in OS response to possible 
biochemical functions of the protein is that a conserved cysteine residue (Cys106) is both 
critical for DJ-1 function and very sensitive to oxidative modification. WT-DJ-1 is modified 
under OS both in vitro and in vivo by oxidation of Cys106 to form a Cys-SO2
-. Cys106 
interacts with a neighboring protonated E18 residue, required for stabilizing the Cys106-SO2
- 
form of DJ-1. To study this important post translational modification, we have tested this 
approach by characterizing the effect of E18 mutations on the cytoprotective activity of 
Cys106 using designed E18 mutations (E18Q and E18D). Comparing cell viability for both 
cell line models of transfected WT-DJ-1(E18) to either DJ-1 mutation forms (E18Q or E18D) 
under naïve or OS condition, our results emphasized and provided additional evidence that the 
formation of Cys106-SO2
- is advantageous for optimal DJ-1 protective function.  
In an effort to characterize DJ-1 mechanism(s) of action, our immunoprecipitation data 
identified possible interacting protein partners supporting and strengthening pre-existing 
postulated determinations for DJ-1 potential pathways (summarized in Fig. 4.1). Summing up, 
beyond DJ-1 role as an oxidative sensor or ROS scavenger by self-oxidation, the co-
precipitation of heat shock proteins, the premium chaperones assisting to refold misfolded 
proteins and suppress their aggregation in the presence of OS, provides clues for DJ-1 
suggested chaperone activity. Moreover, the co-purification of GAPDH, possessing functional 
links to apoptosis, with DJ-1 in WT and E18Q but not E18D insights into DJ-1 function at the 
transcriptional level and its cystolic RNA-binding activity and elucidates the drastic negative 


















Figure 4.1: Simplified schematic diagram for protein DJ-1 pathways 
1: DJ-1 itself senses oxidative signals (ROS) via oxidation of the Cys106 residue into sulfinic acid (self-
oxidation).  2: DJ-1 has a chaperone activity by interacting with heat shock proteins (HSP) which helps refolding 
misfolded proteins induced by oxidative and other cell-stress conditions. 3: DJ-1 influences the expression of 
genes for the stress response at transcriptional and post-transcriptional levels by interacting with cytosolic RNA-
binding protein complexes. 4: The latter complexes may also be associated with GAPDH, a protein with 
functional links to apoptosis. Modified from reference 87. 
 
Yet, it is tempting to speculate and investigate the apparent role of  annexins in co-operation 
with DJ-1, being linked to inflammation and involved in apoptotic mechanisms; the over 
expression of ANXA2, in particular, as an OS sensitive protein in the diverse OS experiments, 
its purification as a DJ-1 partner protein, in addition to the recently published finding (189) 
establishing ANXA2 as a novel cellular redox regulatory protein emphasize that ANXA2 is 
unique among other annexins as a redox sensitive protein, a function unmasked in the context 
of OS. On the other hand, answers to the copious debates concerning DJ-1ʼs multiple roles at 
the nuclear and mitochondrial levels (Fig. 4.1) necessitate supplementary efforts to provide 






may yield therapeutic profile and efficacy. The aforementioned points are designed for our 
future work extending our OS project. However, the present data provide a framework linking 
DJ-1 biological actions and generating new sights into the interaction between the complex 
mechanisms of oxidative damage in renal fibrosis. Moreover, implicate a multistep pathway 
for protein DJ-1 each afforded according to the cellular requirement. 
It is worth mentioning that the cellular redox system is complex with significant cross talk 
between various proteins and often several proteins compensate for each other’s function in a 













































It is well established that oxidative stress (OS) is an important cause of cell damage associated 
with the initiation and progression of many diseases including renal diseases. Consequently, 
all living organisms have developed efficient antioxidant defense systems to cope with these 
oxidative conditions and limit OS by detoxifying reactive oxygen species (ROS) in aerobic 
metabolism under normal physiological conditions. These systems are composed of 
antioxidant enzymes and repair proteins. An excess production of ROS may overwhelm the 
antioxidant defense system and cause oxidative damage to various cellular constituents 
including DNA, RNA, proteins, and lipids. A functional proteomics approach used at a wide 
scale in the present study has explored global changes and provided new molecular targets 
linking profibrotic cytokines (ANG II and PDGF) and H2O2-induced OS to cellular 
dysfunction by recognizing changes of protein expression profiles. A number of OS protein 
biomarkers have been compiled from our in vitro study using human renal cell cultures 
(TK173 and HK-2). The regulation of the identified proteins has been interpreted as one of 
the major cellular recovery responses after oxidative damage. The mass spectrometry results 
were documented by Western Blot (WB) analysis of treated cell lysates for a number of OS 
biomarkers.  
With a shift in the pI value in addition to its over expression as a result of oxidation, I 
provided the first evidence for the incorporation of protein DJ-1 (PARK7) as an endogenous 
antioxidant defense protein in renal cells. The knock down of PARK7 in renal cells using 
siRNA dramatically inhibited cell viability as manifested by the morphological changes and 
MTT viability assay and showed high cellular apoptosis after OS induction. Further, WB 
analysis for whole kidney lysates of wild type (WT) and different stages of fibrosis from 
Col4a3 knockout mice as a fibrosis model revealed a parallel increase in response of PARK7 






immunofluorescence staining images of the glomerular and tubulointerstitial areas from 
similar fibrosis successive stages of Col4a3 knockout mice kidneys stained with PARK7 
further documented WB results. 
How may have PARK7 (DJ-1) a benefit in ameliorating the progression of renal fibrosis? I 
aimed to elucidate the molecular mechanisms of PARK7 action to define the role of PARK7 
in balancing OS in renal fibrosis by transfecting cells with plasmids of the WT-DJ-1 and 2 
different mutants. I then identified DJ-1 interaction partners in the different transfected cell 
lysates using affinity purification combined with mass spectrometry. Mutants were chosen 
according to crystallization structural analysis of the purified protein DJ-1 consolidating 
cysteine residue (Cys106) to be the most sensitive to OS and the key modification required for 
DJ-1 to exert its protective function by acting as a sensor of cellular redox homeostasis. 
Results obtained strengthened and emphasized previous reports by displaying that the 
oxidative modification of Cys106 to Cys106-SO2
- is a critical determinant for DJ-1 to protect 
cells against loss of viability. Besides DJ-1 function as ROS scavenger by self-oxidation, my 
immunoprecipitation data provided the following clues: i) DJ-1 seems to have a role at the 
transcriptional and post-transcriptional levels via interacting with cystolic RNA-binding 
protein complexes and, ii) DJ-1 might have a chaperone activity assisting to refold misfolded 
proteins induced by oxidative and other cell-stress conditions. Finally, the strong networking 
of the identified proteins that were detected to cooperate with protein DJ-1 using STRING 
functional protein association networks analysis manifested DJ-1 as a multifunctional protein 
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